AMERICAN SOCIETY OF CLINICAL ONCOLOGY: Form 990, tax year 2019

View the entire original 990 at ProPublica ↗

Organization: AMERICAN SOCIETY OF CLINICAL ONCOLOGY (EIN 13-6180380)
Tax period: 2019-01-01 to 2019-12-31
Filed: 2020-11-03
IRS object ID: 202023089349300732
Schema version: 2019v5.1
Source: Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header
Form 990
Schedule A
Schedule B
Schedule C
Schedule D
Schedule F
Schedule I
Schedule J
Schedule K
Schedule O
Schedule R

Return header ReturnHeader

Field	Value	IRS element (for citing)
Return	2020-11-03T09:34:01-06:00	ReturnTs
Tax Period End	2019-12-31	TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

Preparer Firm Name PreparerFirmName

Field	Value	IRS element (for citing)
Business Name Line1	BDO USA LLP	BusinessNameLine1Txt

Preparer US Address PreparerUSAddress

Field	Value	IRS element (for citing)
Address Line1	8401 GREENSBORO DRIVE 800	AddressLine1Txt
City	MCLEAN	CityNm
State Abbreviation	VA	StateAbbreviationCd
ZIP	22102	ZIPCd

Field	Value	IRS element (for citing)
Return Type	990	ReturnTypeCd
Tax Period Begin	2019-01-01	TaxPeriodBeginDt

Filer Filer

Field	Value	IRS element (for citing)
EIN	136180380	EIN

Business Name BusinessName

Field	Value	IRS element (for citing)
Business Name Line1	AMERICAN SOCIETY OF CLINICAL ONCOLOGY INC	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
In Care Of	% LINDA JENSEN CFO	InCareOfNm
Business Name Control	AMER	BusinessNameControlTxt
Phone	5714831300	PhoneNum

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	2318 MILL ROAD Suite 800	AddressLine1Txt
City	ALEXANDRIA	CityNm
State Abbreviation	VA	StateAbbreviationCd
ZIP	22314	ZIPCd

Business Officer BusinessOfficerGrp

Field	Value	IRS element (for citing)
Person	LINDA JENSEN	PersonNm
Person Title	CFO	PersonTitleTxt
Phone	5714831300	PhoneNum
Signature	2020-11-02	SignatureDt
Discuss With Paid Preparer	Yes (true)	DiscussWithPaidPreparerInd

Preparer Person PreparerPersonGrp

Field	Value	IRS element (for citing)
Preparer Person	Marc Berger	PreparerPersonNm
PTIN	P01871563	PTIN
Phone	7038930600	PhoneNum

Filing Security Information FilingSecurityInformation

IP Address IPAddress

Field	Value	IRS element (for citing)
I Pv4 Address	73.53.153.141	IPv4AddressTxt

Field	Value	IRS element (for citing)
Federal Original Submission Id	54621820203085000005	FederalOriginalSubmissionId
Federal Original Submission Id	2020-11-03	FederalOriginalSubmissionIdDt
Filing License Type	P	FilingLicenseTypeCd
At Submission Creation Device Id	F80C4C4CE64063363A32333BB37C43EAD2BBFD59	AtSubmissionCreationDeviceId
At Submission Filing Device Id	F80C4C4CE64063363A32333BB37C43EAD2BBFD59	AtSubmissionFilingDeviceId

Field	Value	IRS element (for citing)
Tax	2019	TaxYr
Build TS	2021-01-29 14:40:06Z	BuildTS

Form 990 IRS990

Field	Value	IRS element (for citing)
Principal Officer	CLIFFORD HUDIS MD CEO	PrincipalOfficerNm

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	2318 MILL ROAD 800	AddressLine1Txt
City	ALEXANDRIA	CityNm
State Abbreviation	VA	StateAbbreviationCd
ZIP	22314	ZIPCd

Field	Value	IRS element (for citing)
Gross Receipts	$164,682,134	GrossReceiptsAmt
Group Return For Affiliates	false	GroupReturnForAffiliatesInd
Organization501c3	Yes (X)	Organization501c3Ind
Website Address	WWW.ASCO.ORG	WebsiteAddressTxt
Type Of Organization Corp	Yes (X)	TypeOfOrganizationCorpInd
Formation	1964	FormationYr
Legal Domicile State	NY	LegalDomicileStateCd
Activity Or Mission	ASCO IS A PROFESSIONAL ONCOLOGY SOCIETY COMMITTED TO CONQUERING CANCER THROUGH RESEARCH, EDUCATION, AND PROMOTION OF THE HIGHEST QUALITY AND EQUITABLE PATIENT CARE.	ActivityOrMissionDesc
Voting Members Governing Body	18	VotingMembersGoverningBodyCnt
Voting Members Independent	18	VotingMembersIndependentCnt
Total Employee	564	TotalEmployeeCnt
Total Volunteers	2981	TotalVolunteersCnt
Total Gross UBI	$22,759,889	TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm	$7,625,514	NetUnrelatedBusTxblIncmAmt
PY Contributions Grants	$8,575,801	PYContributionsGrantsAmt
CY Contributions Grants	$7,525,300	CYContributionsGrantsAmt
PY Program Service Revenue	$136,574,903	PYProgramServiceRevenueAmt
CY Program Service Revenue	$145,628,204	CYProgramServiceRevenueAmt
PY Investment Income	$11,398,200	PYInvestmentIncomeAmt
CY Investment Income	$6,514,346	CYInvestmentIncomeAmt
PY Other Revenue	$3,335,190	PYOtherRevenueAmt
CY Other Revenue	$3,043,571	CYOtherRevenueAmt
PY Total Revenue	$159,884,094	PYTotalRevenueAmt
CY Total Revenue	$162,711,421	CYTotalRevenueAmt
PY Grants And Similar Paid	$1,168,748	PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid	$2,492,264	CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members	$0	PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members	$0	CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid	$59,231,331	PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid	$61,964,764	CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns	$0	PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns	$0	CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense	$3,350,660	CYTotalFundraisingExpenseAmt
PY Other Expenses	$85,406,395	PYOtherExpensesAmt
CY Other Expenses	$83,651,841	CYOtherExpensesAmt
PY Total Expenses	$145,806,474	PYTotalExpensesAmt
CY Total Expenses	$148,108,869	CYTotalExpensesAmt
PY Revenues Less Expenses	$14,077,620	PYRevenuesLessExpensesAmt
CY Revenues Less Expenses	$14,602,552	CYRevenuesLessExpensesAmt
Total Assets BOY	$227,652,015	TotalAssetsBOYAmt
Total Assets EOY	$269,484,782	TotalAssetsEOYAmt
Total Liabilities BOY	$118,594,943	TotalLiabilitiesBOYAmt
Total Liabilities EOY	$131,909,947	TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY	$109,057,072	NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY	$137,574,835	NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part III	Yes (X)	InfoInScheduleOPartIIIInd
Mission	SEE SCHEDULE O	MissionDesc
Significant New Program Srvc	false	SignificantNewProgramSrvcInd
Significant Change	false	SignificantChangeInd
Expense	$45,034,199	ExpenseAmt
Grant	$622,505	GrantAmt
Revenue	$75,048,988	RevenueAmt
Desc	SCIENTIFIC AND MEDICAL EDUCATION: SEE SCHEDULE O	Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

Field	Value	IRS element (for citing)
Expense	$39,058,114	ExpenseAmt
Grant	$5,000	GrantAmt
Revenue	$23,830,960	RevenueAmt
Desc	QUALITY OF CARE: SEE SCHEDULE O	Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

Field	Value	IRS element (for citing)
Expense	$14,973,319	ExpenseAmt
Grant	$57,500	GrantAmt
Revenue	$32,305,592	RevenueAmt
Desc	EDUCATIONAL PUBLICATIONS: SEE SCHEDULE O	Desc

Field	Value	IRS element (for citing)
Total Other Prog Srvc Expense	$35,073,915	TotalOtherProgSrvcExpenseAmt
Total Other Prog Srvc Grant	$1,767,383	TotalOtherProgSrvcGrantAmt
Total Other Prog Srvc Revenue	$14,442,664	TotalOtherProgSrvcRevenueAmt
Total Program Service Expenses	$134,139,547	TotalProgramServiceExpensesAmt
Described In Section501c3	Yes (true)	DescribedInSection501c3Ind
Schedule B Required	Yes (true)	ScheduleBRequiredInd
Political Campaign Acty	false	PoliticalCampaignActyInd
Lobbying Activities	Yes (true)	LobbyingActivitiesInd
Subject To Proxy Tax	false	SubjectToProxyTaxInd
Donor Advised Fund	false	DonorAdvisedFundInd
Conservation Easements	false	ConservationEasementsInd
Collections Of Art	false	CollectionsOfArtInd
Credit Counseling	false	CreditCounselingInd
Donor Rstr Or Quasi Endowments	false	DonorRstrOrQuasiEndowmentsInd
Report Land Building Equipment	Yes (true)	ReportLandBuildingEquipmentInd
Report Investments Other Sec	false	ReportInvestmentsOtherSecInd
Report Program Related Invst	false	ReportProgramRelatedInvstInd
Report Other Assets	false	ReportOtherAssetsInd
Report Other Liabilities	Yes (true)	ReportOtherLiabilitiesInd
Include FIN48 Footnote	Yes (true)	IncludeFIN48FootnoteInd
Independent Audit Fincl Stmt	false	IndependentAuditFinclStmtInd
Consolidated Audit Fincl Stmt	Yes (true)	ConsolidatedAuditFinclStmtInd
School Operating	false	SchoolOperatingInd
Foreign Office	Yes (true)	ForeignOfficeInd
Foreign Activities	Yes (true)	ForeignActivitiesInd
More Than5000 K To Org	Yes (true)	MoreThan5000KToOrgInd
More Than5000 K To Individuals	Yes (true)	MoreThan5000KToIndividualsInd
Professional Fundraising	false	ProfessionalFundraisingInd
Fundraising Activities	false	FundraisingActivitiesInd
Gaming Activities	false	GamingActivitiesInd
Operate Hospital	false	OperateHospitalInd
Grants To Organizations	Yes (true)	GrantsToOrganizationsInd
Grants To Individuals	false	GrantsToIndividualsInd
Schedule J Required	Yes (true)	ScheduleJRequiredInd
Tax Exempt Bonds	Yes (true)	TaxExemptBondsInd
Invest Tax Exempt Bonds	false	InvestTaxExemptBondsInd
Escrow Account	false	EscrowAccountInd
On Behalf Of Issuer	false	OnBehalfOfIssuerInd
Engaged In Excess Benefit Trans	false	EngagedInExcessBenefitTransInd
PY Excess Benefit Trans	false	PYExcessBenefitTransInd
Loan Outstanding	false	LoanOutstandingInd
Grant To Related Person	false	GrantToRelatedPersonInd
Business Rln With Org Mem	false	BusinessRlnWithOrgMemInd
Business Rln With Fam Mem	false	BusinessRlnWithFamMemInd
Business Rln With35 Ctrl Ent	false	BusinessRlnWith35CtrlEntInd
Deductible Non Cash Contri	false	DeductibleNonCashContriInd
Deductible Art Contribution	false	DeductibleArtContributionInd
Terminate Operations	false	TerminateOperationsInd
Partial Liquidation	false	PartialLiquidationInd
Disregarded Entity	Yes (true)	DisregardedEntityInd
Related Entity	Yes (true)	RelatedEntityInd
Related Organization Ctrl Ent	Yes (true)	RelatedOrganizationCtrlEntInd
Transaction With Control Ent	Yes (true)	TransactionWithControlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org	false	TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp	false	ActivitiesConductedPrtshpInd
Schedule O Required	Yes (true)	ScheduleORequiredInd
IRP Document	464	IRPDocumentCnt
IRP Document W2 G	0	IRPDocumentW2GCnt
Backup Wthld Compliance	Yes (true)	BackupWthldComplianceInd
Employee	564	EmployeeCnt
Employment Tax Returns Filed	Yes (true)	EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over Limit	Yes (true)	UnrelatedBusIncmOverLimitInd
Form990 T Filed	Yes (true)	Form990TFiledInd
Foreign Financial Account	false	ForeignFinancialAccountInd
Prohibited Tax Shelter Trans	false	ProhibitedTaxShelterTransInd
Taxable Party Notification	false	TaxablePartyNotificationInd
Nondeductible Contributions	false	NondeductibleContributionsInd
Quid Pro Quo Contributions	false	QuidProQuoContributionsInd
Form8282 Property Disposed Of	false	Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct	false	RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct	false	PayPremiumsPrsnlBnftCntrctInd
Indoor Tanning Services	false	IndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht Pymt	false	SubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst Inc	false	SubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VI	Yes (X)	InfoInScheduleOPartVIInd
Governing Body Voting Members	18	GoverningBodyVotingMembersCnt
Independent Voting Member	18	IndependentVotingMemberCnt
Family Or Business Rln	false	FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties	false	DelegationOfMgmtDutiesInd
Change To Org Documents	Yes (true)	ChangeToOrgDocumentsInd
Material Diversion Or Misuse	false	MaterialDiversionOrMisuseInd
Members Or Stockholders	Yes (true)	MembersOrStockholdersInd
Election Of Board Members	Yes (true)	ElectionOfBoardMembersInd
Decisions Subject To Approva	Yes (true)	DecisionsSubjectToApprovaInd
Minutes Of Governing Body	Yes (true)	MinutesOfGoverningBodyInd
Minutes Of Committees	Yes (true)	MinutesOfCommitteesInd
Officer Mailing Address	false	OfficerMailingAddressInd
Local Chapters	false	LocalChaptersInd
Form990 Provided To Gvrn Body	Yes (true)	Form990ProvidedToGvrnBodyInd
Conflict Of Interest Policy	Yes (true)	ConflictOfInterestPolicyInd
Annual Disclosure Covered Prsn	Yes (true)	AnnualDisclosureCoveredPrsnInd
Regular Monitoring Enfrc	Yes (true)	RegularMonitoringEnfrcInd
Whistleblower Policy	Yes (true)	WhistleblowerPolicyInd
Document Retention Policy	Yes (true)	DocumentRetentionPolicyInd
Compensation Process CEO	Yes (true)	CompensationProcessCEOInd
Compensation Process Other	Yes (true)	CompensationProcessOtherInd
Investment In Joint Venture	false	InvestmentInJointVentureInd
States Where Copy Of Return Is Fld	CA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NY	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	VA	StatesWhereCopyOfReturnIsFldCd
Upon Request	Yes (X)	UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

Field	Value	IRS element (for citing)
Person	LINDA JENSEN CFO	PersonNm
Phone	5714831300	PhoneNum

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	2318 MILL ROAD SUITE 800	AddressLine1Txt
City	ALEXANDRIA	CityNm
State Abbreviation	VA	StateAbbreviationCd
ZIP	22314	ZIPCd

Field	Value	IRS element (for citing)
Info In Schedule O Part VII	Yes (X)	InfoInScheduleOPartVIIInd

Form990 Part VII Section A Form990PartVIISectionAGrp (41 entries)

TitleTitleTxt	Average Hours Per WeekAverageHoursPerWeekRt	Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt	OfficerOfficerInd	Reportable Comp From OrgReportableCompFromOrgAmt	Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt	Other CompensationOtherCompensationAmt	Key EmployeeKeyEmployeeInd	Highest Compensated EmployeeHighestCompensatedEmployeeInd	Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd
Clifford HudisMD
CEO, NON-VOTING DIRECTOR	36.0	1.5	Yes (X)	$898,194	$0	$24,233
Dina Michels Esq
EVP, CHIEF LEGAL OFFICER	36.0	1.5	Yes (X)	$581,731	$0	$39,055
Richard Schilsky MD
EVP, Chief Medical Officer	37.5	0.0		$576,789	$0	$37,756	Yes (X)
Bernie Khoo
VP, INFORMATION TECHNOLOGY	37.5	0.0		$429,423	$0	$43,541	Yes (X)
CORY WIEGERT
EVP, CEO CANCERLINQ	37.5	0.0		$414,423	$0	$47,574	Yes (X)
Linda Jensen MBA
EVP, Chief Financial Officer	36.0	1.5	Yes (X)	$401,924	$0	$38,536
Stephen Grubbs MD
VP, Clinical Affairs	37.5	0.0		$391,923	$0	$37,756		Yes (X)
Nancy Daly MS MPH
EVP, CHIEF PHILANTHROPIC OFF.	3.0	34.5		$387,673	$0	$38,537	Yes (X)
Jamie Von Roenn MD
VP, Education	37.5	0.0		$392,173	$0	$31,472	Yes (X)
Robert Miller MD
MEDICAL DIRECTOR, CANCERLINQ	37.5	0.0		$362,119	$0	$43,811		Yes (X)
CARMEN JACKSON
COO, CANCERLINQ	37.5	0.0		$314,738	$0	$43,811		Yes (X)
Deborah Kamin RN PHD
VP, POLICY AND ADVOCACY	37.5	0.0		$307,923	$0	$38,537	Yes (X)
Kristin Ludwig
VP, MKTG. & Communications	36.5	1.0		$306,192	$0	$24,233	Yes (X)
ANIL NAIR
CTO, CANCERLINQ	37.5	0.0		$291,546	$0	$36,301		Yes (X)
DAVID SAMPSON
VP, JOURNALS & PUBLISHER	37.5	0.0		$281,211	$0	$43,321	Yes (X)
CAROLYN WHITEHEAD
DIVISION DIR., CONQUER CANCER	1.0	36.5		$294,412	$0	$22,524		Yes (X)
Krista Barnes
VP, Member Services	37.5	0.0		$257,496	$0	$41,475	Yes (X)
Amanda Davis-Aitken
VP, Meeting Services	37.5	0.0		$255,192	$0	$28,656	Yes (X)
CHRISTOPHER MERLAN
EVP, CHIEF DIGITAL OFFICER	37.5	0.0		$145,269	$0	$9,338	Yes (X)
BLASE N POLITE MD M
BOARD MEMBER	1.0	0.0		$3,625	$0	$0			Yes (X)
MICHAEL A THOMPSON M
BOARD MEMBER	1.0	0.0		$2,500	$0	$0			Yes (X)
Bruce Johnson MD
PAST President - PARTIAL YEAR	1.0	0.0	Yes (X)	$0	$0	$0			Yes (X)
Monica Bertagnolli MD
President/Chair	1.0	0.0	Yes (X)	$0	$0	$0			Yes (X)
Peter Adamson MD
Board Member	1.0	0.0		$0	$0	$0			Yes (X)
Stephen B Edge MD
Board Member	1.0	0.0		$0	$0	$0			Yes (X)
Maha HussainMD
Board Member	1.0	0.0		$0	$0	$0			Yes (X)
J Chris Nunnink MD
Board Member	1.0	0.0		$0	$0	$0			Yes (X)
Reshma Jagsi MD Dphi
Board Member	1.0	0.0		$0	$0	$0			Yes (X)
Michael KostyMD
Board Member	1.0	0.0		$0	$0	$0			Yes (X)
Eric Small MD
Board Member	1.0	0.0		$0	$0	$0			Yes (X)
Jedd Wolchok MD PHD
Board Member	1.0	0.0		$0	$0	$0			Yes (X)
HOWARD A BURRIS III
PRESIDENT-ELECT/President	1.0	0.0	Yes (X)	$0	$0	$0			Yes (X)
LAURIE GASPAR MDMBA
TREASURER	1.0	0.0	Yes (X)	$0	$0	$0			Yes (X)
A WILLIAM BLACKSTOCK
BOARD MEMBER	1.0	0.0		$0	$0	$0			Yes (X)
LEE ELLIS MD FACS
BOARD MEMBER	1.0	0.0		$0	$0	$0			Yes (X)
TONY SHU KAM MOK MD
BOARD MEMBER	1.0	0.0		$0	$0	$0			Yes (X)
JAAP VERWEIJ MD PHD
BOARD MEMBER	1.0	0.0		$0	$0	$0			Yes (X)
TRACEY WEISBERG MD
BOARD MEMBER	1.0	0.0		$0	$0	$0			Yes (X)
Lori J Pierce MD
President Elect	1.0	0.0	Yes (X)	$0	$0	$0			Yes (X)
ELIZABETH A MITTENDOR
BOARD MEMBER	1.0	0.0		$0	$0	$0			Yes (X)
ETHAN M BASCH MD
BOARD MEMBER	1.0	0.0		$0	$0	$0			Yes (X)

Field	Value	IRS element (for citing)
Total Reportable Comp From Org	$7,296,476	TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org	$0	TotReportableCompRltdOrgAmt
Total Other Compensation	$670,467	TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K	184	IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed	false	FormerOfcrEmployeesListedInd
Total Comp Greater Than150 K	Yes (true)	TotalCompGreaterThan150KInd
Compensation From Other Srcs	false	CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Address Line1ContractorAddress/USAddress/AddressLine1Txt	CityContractorAddress/USAddress/CityNm	State AbbreviationContractorAddress/USAddress/StateAbbreviationCd	ZIPContractorAddress/USAddress/ZIPCd	ServicesServicesDesc	CompensationCompensationAmt
TEMPUS LABS
600 WEST CHICAGO AVE	CHICAGO	IL	60654	DATA CURATION SVC	$3,773,700
SPARGO INC
PO 828795	PHILADELPHIA	PA	191828795	EVENT PLANNING SVC	$2,970,147
AMAZON WEB SERVICE
PO BOX 84023	SEATTLE	WA	981248423	CLOUD COMPUTING SVC	$2,559,170
FREEMAN DECORATING
PO BOX 660613	DALLAS	TX	725660613	EVENT PLANNING SVC	$2,405,197
DARTMOUTH PRINTING COMPANY
PO BOX 419817	BOSTON	MA	022419817	PRINTING SERVICE	$1,998,136

Field	Value	IRS element (for citing)
Cntrct Rcvd Greater Than100 K	76	CntrctRcvdGreaterThan100KCnt
Related Organizations	$7,525,300	RelatedOrganizationsAmt
Total Contributions	$7,525,300	TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp (5 entries)

DescDesc	BusinessBusinessCd	Total Revenue ColumnTotalRevenueColumnAmt	Related Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt	Unrelated Business RevenueUnrelatedBusinessRevenueAmt
DUES	900099	$7,155,214	$7,155,214
EDUCATIONAL MEETINGS & PRODUCTS	900099	$75,048,988	$69,127,504	$5,921,484
EDUCATIONAL PUBLICATIONS	511190	$32,305,592	$17,052,037	$15,253,555
QUALITY	900099	$23,830,960	$22,843,799	$987,161
MEMBER RELATIONS & INFORMATION	900099	$349,049		$349,049

Total Oth Program Service Rev TotalOthProgramServiceRevGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$6,938,401	TotalRevenueColumnAmt
Related Or Exempt Func Income	$6,938,401	RelatedOrExemptFuncIncomeAmt

Field	Value	IRS element (for citing)
Total Program Service Revenue	$145,628,204	TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$6,066,749	TotalRevenueColumnAmt
Exclusion	$6,066,749	ExclusionAmt

Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$0	TotalRevenueColumnAmt

Royalties Revenue RoyaltiesRevenueGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$2,543,846	TotalRevenueColumnAmt
Exclusion	$2,543,846	ExclusionAmt

Gross Rents GrossRentsGrp

Field	Value	IRS element (for citing)
Real	$582,855	RealAmt

Less Rental Expenses LessRentalExpensesGrp

Field	Value	IRS element (for citing)
Real	$334,215	RealAmt

Rental Income Or Loss RentalIncomeOrLossGrp

Field	Value	IRS element (for citing)
Real	$248,640	RealAmt
Personal	$0	PersonalAmt

Net Rental Income Or Loss NetRentalIncomeOrLossGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$248,640	TotalRevenueColumnAmt
Unrelated Business Revenue	$248,640	UnrelatedBusinessRevenueAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

Field	Value	IRS element (for citing)
Securities	$2,084,095	SecuritiesAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

Field	Value	IRS element (for citing)
Securities	$1,636,498	SecuritiesAmt

Gain Or Loss GainOrLossGrp

Field	Value	IRS element (for citing)
Securities	$447,597	SecuritiesAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$447,597	TotalRevenueColumnAmt
Exclusion	$447,597	ExclusionAmt

Field	Value	IRS element (for citing)
Fundraising Gross Income	$0	FundraisingGrossIncomeAmt
Fundraising Direct Expenses	$0	FundraisingDirectExpensesAmt

Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$0	TotalRevenueColumnAmt

Field	Value	IRS element (for citing)
Gaming Gross Income	$0	GamingGrossIncomeAmt
Gaming Direct Expenses	$0	GamingDirectExpensesAmt

Net Income From Gaming NetIncomeFromGamingGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$0	TotalRevenueColumnAmt

Field	Value	IRS element (for citing)
Gross Sales Of Inventory	$0	GrossSalesOfInventoryAmt
Cost Of Goods Sold	$0	CostOfGoodsSoldAmt

Net Income Or Loss NetIncomeOrLossGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$0	TotalRevenueColumnAmt

Other Revenue Misc OtherRevenueMiscGrp

Field	Value	IRS element (for citing)
Desc	MAILING LIST	Desc
Total Revenue Column	$251,085	TotalRevenueColumnAmt
Exclusion	$251,085	ExclusionAmt

Field	Value	IRS element (for citing)
Other Revenue Total	$251,085	OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$162,711,421	TotalRevenueColumnAmt
Related Or Exempt Func Income	$123,116,955	RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue	$22,759,889	UnrelatedBusinessRevenueAmt
Exclusion	$9,309,277	ExclusionAmt

Field	Value	IRS element (for citing)
Info In Schedule O Part IX	Yes (X)	InfoInScheduleOPartIXInd

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

Field	Value	IRS element (for citing)
Total	$2,287,513	TotalAmt
Program Services	$2,287,513	ProgramServicesAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Foreign Grants ForeignGrantsGrp

Field	Value	IRS element (for citing)
Total	$204,751	TotalAmt
Program Services	$204,751	ProgramServicesAmt

Benefits To Members BenefitsToMembersGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

Field	Value	IRS element (for citing)
Total	$6,438,819	TotalAmt
Program Services	$3,119,741	ProgramServicesAmt
Management And General	$3,120,419	ManagementAndGeneralAmt
Fundraising	$198,659	FundraisingAmt

Comp Disqual Persons CompDisqualPersonsGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

Field	Value	IRS element (for citing)
Total	$44,563,815	TotalAmt
Program Services	$41,232,294	ProgramServicesAmt
Management And General	$3,331,521	ManagementAndGeneralAmt

Pension Plan Contributions PensionPlanContributionsGrp

Field	Value	IRS element (for citing)
Total	$2,993,232	TotalAmt
Program Services	$2,808,746	ProgramServicesAmt
Management And General	$184,486	ManagementAndGeneralAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

Field	Value	IRS element (for citing)
Total	$4,213,614	TotalAmt
Program Services	$3,915,784	ProgramServicesAmt
Management And General	$297,830	ManagementAndGeneralAmt

Payroll Taxes PayrollTaxesGrp

Field	Value	IRS element (for citing)
Total	$3,755,284	TotalAmt
Program Services	$3,463,551	ProgramServicesAmt
Management And General	$291,733	ManagementAndGeneralAmt

Fees For Services Management FeesForServicesManagementGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Fees For Services Legal FeesForServicesLegalGrp

Field	Value	IRS element (for citing)
Total	$533,024	TotalAmt
Program Services	$528,619	ProgramServicesAmt
Management And General	$4,405	ManagementAndGeneralAmt

Fees For Services Accounting FeesForServicesAccountingGrp

Field	Value	IRS element (for citing)
Total	$183,472	TotalAmt
Program Services	$2,375	ProgramServicesAmt
Management And General	$181,097	ManagementAndGeneralAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

Field	Value	IRS element (for citing)
Total	$290,516	TotalAmt
Program Services	$290,516	ProgramServicesAmt

Fees For Services Prof Fundraising FeesForServicesProfFundraising

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

Field	Value	IRS element (for citing)
Total	$79,584	TotalAmt
Management And General	$79,584	ManagementAndGeneralAmt

Fees For Services Other FeesForServicesOtherGrp

Field	Value	IRS element (for citing)
Total	$27,897,419	TotalAmt
Program Services	$27,728,640	ProgramServicesAmt
Management And General	$168,445	ManagementAndGeneralAmt
Fundraising	$334	FundraisingAmt

Advertising AdvertisingGrp

Field	Value	IRS element (for citing)
Total	$585,630	TotalAmt
Program Services	$582,672	ProgramServicesAmt
Management And General	$2,958	ManagementAndGeneralAmt

Office Expenses OfficeExpensesGrp

Field	Value	IRS element (for citing)
Total	$2,529,096	TotalAmt
Program Services	$2,318,566	ProgramServicesAmt
Management And General	$210,530	ManagementAndGeneralAmt

Information Technology InformationTechnologyGrp

Field	Value	IRS element (for citing)
Total	$8,595,316	TotalAmt
Program Services	$8,299,877	ProgramServicesAmt
Management And General	$294,845	ManagementAndGeneralAmt
Fundraising	$594	FundraisingAmt

Royalties RoyaltiesGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Occupancy OccupancyGrp

Field	Value	IRS element (for citing)
Total	$3,014,972	TotalAmt
Program Services	$2,931,523	ProgramServicesAmt
Management And General	$83,449	ManagementAndGeneralAmt

Travel TravelGrp

Field	Value	IRS element (for citing)
Total	$6,468,203	TotalAmt
Program Services	$6,221,588	ProgramServicesAmt
Management And General	$245,542	ManagementAndGeneralAmt
Fundraising	$1,073	FundraisingAmt

Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Conferences Meetings ConferencesMeetingsGrp

Field	Value	IRS element (for citing)
Total	$14,272,170	TotalAmt
Program Services	$13,818,850	ProgramServicesAmt
Management And General	$453,320	ManagementAndGeneralAmt

Interest InterestGrp

Field	Value	IRS element (for citing)
Total	$2,651,464	TotalAmt
Program Services	$2,092,645	ProgramServicesAmt
Management And General	$558,819	ManagementAndGeneralAmt

Payments To Affiliates PaymentsToAffiliatesGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Depreciation Depletion DepreciationDepletionGrp

Field	Value	IRS element (for citing)
Total	$3,037,458	TotalAmt
Program Services	$2,410,091	ProgramServicesAmt
Management And General	$627,367	ManagementAndGeneralAmt

Insurance InsuranceGrp

Field	Value	IRS element (for citing)
Total	$687,702	TotalAmt
Program Services	$209,558	ProgramServicesAmt
Management And General	$478,144	ManagementAndGeneralAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDesc	TotalTotalAmt	Program ServicesProgramServicesAmt	Management And GeneralManagementAndGeneralAmt	FundraisingFundraisingAmt
PRINTING & PRODUCTION	$4,834,824	$4,833,353	$1,471
DEVELOPMENT FEE TO RELATED ORG	$3,150,000	$0	$0	$3,150,000
UBI TAX	$1,251,310	$1,250,935	$375	$0
POSTAGE & SHIPPING	$1,211,639	$1,209,927	$1,712	$0

All Other Expenses AllOtherExpensesGrp

Field	Value	IRS element (for citing)
Total	$2,378,042	TotalAmt
Program Services	$2,377,432	ProgramServicesAmt
Management And General	$610	ManagementAndGeneralAmt

Total Functional Expenses TotalFunctionalExpensesGrp

Field	Value	IRS element (for citing)
Total	$148,108,869	TotalAmt
Program Services	$134,139,547	ProgramServicesAmt
Management And General	$10,618,662	ManagementAndGeneralAmt
Fundraising	$3,350,660	FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

Field	Value	IRS element (for citing)
BOY	$10,106,685	BOYAmt
EOY	$18,722,737	EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Accounts Receivable AccountsReceivableGrp

Field	Value	IRS element (for citing)
BOY	$16,453,791	BOYAmt
EOY	$26,850,085	EOYAmt

Receivables From Officers Etc ReceivablesFromOfficersEtcGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Inventories For Sale Or Use InventoriesForSaleOrUseGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

Field	Value	IRS element (for citing)
BOY	$7,481,194	BOYAmt
EOY	$7,946,486	EOYAmt

Field	Value	IRS element (for citing)
Land Bldg Equip Cost Or Other Bss	$78,793,752	LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec	$30,659,003	LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

Field	Value	IRS element (for citing)
BOY	$49,050,243	BOYAmt
EOY	$48,134,749	EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

Field	Value	IRS element (for citing)
BOY	$142,567,125	BOYAmt
EOY	$167,830,725	EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

Field	Value	IRS element (for citing)
BOY	$1,992,977	BOYAmt
EOY	$0	EOYAmt

Investments Program Related InvestmentsProgramRelatedGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Intangible Assets IntangibleAssetsGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Other Assets Total OtherAssetsTotalGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Total Assets TotalAssetsGrp

Field	Value	IRS element (for citing)
BOY	$227,652,015	BOYAmt
EOY	$269,484,782	EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

Field	Value	IRS element (for citing)
BOY	$17,199,923	BOYAmt
EOY	$18,849,700	EOYAmt

Grants Payable GrantsPayableGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Deferred Revenue DeferredRevenueGrp

Field	Value	IRS element (for citing)
BOY	$31,345,157	BOYAmt
EOY	$37,609,894	EOYAmt

Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$38,400,000	BOYAmt
EOY	$38,400,000	EOYAmt

Escrow Account Liability EscrowAccountLiabilityGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Loans From Officers Directors LoansFromOfficersDirectorsGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Other Liabilities OtherLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$31,649,863	BOYAmt
EOY	$37,050,353	EOYAmt

Total Liabilities TotalLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$118,594,943	BOYAmt
EOY	$131,909,947	EOYAmt

Field	Value	IRS element (for citing)
Organization Follows FASB117	Yes (X)	OrganizationFollowsFASB117Ind

No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$109,057,072	BOYAmt
EOY	$136,574,835	EOYAmt

Donor Restriction Net Assets DonorRestrictionNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$1,000,000	EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

Field	Value	IRS element (for citing)
BOY	$109,057,072	BOYAmt
EOY	$137,574,835	EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

Field	Value	IRS element (for citing)
BOY	$227,652,015	BOYAmt
EOY	$269,484,782	EOYAmt

Field	Value	IRS element (for citing)
Info In Schedule O Part XI	Yes (X)	InfoInScheduleOPartXIInd
Reconcilation Revenue Expnss	$14,602,552	ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst	$16,856,803	NetUnrlzdGainsLossesInvstAmt
Other Changes In Net Assets	-$2,941,592	OtherChangesInNetAssetsAmt
Method Of Accounting Accrual	Yes (X)	MethodOfAccountingAccrualInd
Accountant Compile Or Review	false	AccountantCompileOrReviewInd
FS Audited	Yes (true)	FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

Field	Value	IRS element (for citing)
Consolidated Basis Fincl Stmt	Yes (X)	ConsolidatedBasisFinclStmtInd

Field	Value	IRS element (for citing)
Audit Committee	Yes (true)	AuditCommitteeInd
Federal Grant Audit Required	false	FederalGrantAuditRequiredInd

Schedule A IRS990ScheduleA

Field	Value	IRS element (for citing)
Publicly Supported Org509a2	Yes (X)	PubliclySupportedOrg509a2Ind

Gifts Grants Contris Rcvd509 GiftsGrantsContrisRcvd509Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$13,960,857	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$11,941,446	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$9,978,694	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$8,575,801	CurrentTaxYearMinus1YearAmt
Current Tax Year	$7,525,300	CurrentTaxYearAmt
Total	$51,982,098	TotalAmt

Gross Receipts Admissions GrossReceiptsAdmissionsGrp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$88,958,786	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$78,719,498	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$93,297,144	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$136,574,903	CurrentTaxYearMinus1YearAmt
Current Tax Year	$123,116,955	CurrentTaxYearAmt
Total	$520,667,286	TotalAmt

Gross Receipts Non Unrlt Bus GrossReceiptsNonUnrltBusGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Tax Rev Levied Orgnztnl Bnft509 TaxRevLeviedOrgnztnlBnft509Grp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Govt Furn Srvc Fclts Vl509 GovtFurnSrvcFcltsVl509Grp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Total509 Total509Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$102,919,643	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$90,660,944	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$103,275,838	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$145,150,704	CurrentTaxYearMinus1YearAmt
Current Tax Year	$130,642,255	CurrentTaxYearAmt
Total	$572,649,384	TotalAmt

Amounts Rcvd Dsqlfy Person AmountsRcvdDsqlfyPersonGrp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$13,914,277	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$11,641,675	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$9,856,323	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$8,575,801	CurrentTaxYearMinus1YearAmt
Current Tax Year	$7,525,300	CurrentTaxYearAmt
Total	$51,513,376	TotalAmt

Substantial Contributors Amt SubstantialContributorsAmtGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Subst And Dsqlfy Prsns Tot SubstAndDsqlfyPrsnsTotGrp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$13,914,277	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$11,641,675	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$9,856,323	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$8,575,801	CurrentTaxYearMinus1YearAmt
Current Tax Year	$7,525,300	CurrentTaxYearAmt
Total	$51,513,376	TotalAmt

Field	Value	IRS element (for citing)
Public Support Total509	$521,136,008	PublicSupportTotal509Amt

Gross Investment Income509 GrossInvestmentIncome509Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$6,401,944	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$5,651,063	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$5,969,247	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$7,763,043	CurrentTaxYearMinus1YearAmt
Current Tax Year	$8,610,595	CurrentTaxYearAmt
Total	$34,395,892	TotalAmt

Post1975 UBTI Post1975UBTIGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Investment Income And UBTI InvestmentIncomeAndUBTIGrp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$6,401,944	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$5,651,063	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$5,969,247	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$7,763,043	CurrentTaxYearMinus1YearAmt
Current Tax Year	$8,610,595	CurrentTaxYearAmt
Total	$34,395,892	TotalAmt

Net Income From Other UBI NetIncomeFromOtherUBIGrp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$3,133,751	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$3,414,649	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$2,871,782	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$4,855,029	CurrentTaxYearMinus1YearAmt
Current Tax Year	$7,776,132	CurrentTaxYearAmt
Total	$22,051,343	TotalAmt

Other Income509 OtherIncome509Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$306,781	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$277,776	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$248,859	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$255,345	CurrentTaxYearMinus1YearAmt
Current Tax Year	$251,085	CurrentTaxYearAmt
Total	$1,339,846	TotalAmt

Total Support Calendar Year TotalSupportCalendarYearGrp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$112,762,119	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$100,004,432	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$112,365,726	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$158,024,121	CurrentTaxYearMinus1YearAmt
Current Tax Year	$147,280,067	CurrentTaxYearAmt
Total	$630,436,465	TotalAmt

Field	Value	IRS element (for citing)
Public Support CY509	0.82663	PublicSupportCY509Pct
Public Support PY509	0.81649	PublicSupportPY509Pct
Investment Income CY	0.05456	InvestmentIncomeCYPct
Investment Income PY	0.05400	InvestmentIncomePYPct
Thirty Thr Pct Suprt Tests CY509	Yes (X)	ThirtyThrPctSuprtTestsCY509Ind

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

Field	Value	IRS element (for citing)
Contributor	RESTRICTED	ContributorNum

Contributor Business Name ContributorBusinessName

Field	Value	IRS element (for citing)
Business Name Line1	RESTRICTED	BusinessNameLine1

Contributor US Address ContributorUSAddress

Field	Value	IRS element (for citing)
Address Line1	RESTRICTED	AddressLine1
Address Line2	RESTRICTED	AddressLine2
City	RESTRICTED	City
State	RESTRICTED	State
ZIP Code	RESTRICTED	ZIPCode

Field	Value	IRS element (for citing)
Total Contributions	RESTRICTED	TotalContributionsAmt

Schedule C IRS990ScheduleC

Total Grassroots Lobbying TotalGrassrootsLobbyingGrp

Field	Value	IRS element (for citing)
Filing Organizations Total	$263	FilingOrganizationsTotalAmt

Total Direct Lobbying TotalDirectLobbyingGrp

Field	Value	IRS element (for citing)
Filing Organizations Total	$439,341	FilingOrganizationsTotalAmt

Total Lobbying Expend TotalLobbyingExpendGrp

Field	Value	IRS element (for citing)
Filing Organizations Total	$439,604	FilingOrganizationsTotalAmt

Other Exempt Purpose Expend OtherExemptPurposeExpendGrp

Field	Value	IRS element (for citing)
Filing Organizations Total	$133,699,943	FilingOrganizationsTotalAmt

Total Exempt Purpose Expend TotalExemptPurposeExpendGrp

Field	Value	IRS element (for citing)
Filing Organizations Total	$134,139,547	FilingOrganizationsTotalAmt

Lobbying Nontaxable Amount LobbyingNontaxableAmountGrp

Field	Value	IRS element (for citing)
Filing Organizations Total	$1,000,000	FilingOrganizationsTotalAmt

Grassroots Nontaxable GrassrootsNontaxableGrp

Field	Value	IRS element (for citing)
Filing Organizations Total	$250,000	FilingOrganizationsTotalAmt

Field	Value	IRS element (for citing)
Tot Lbbyng Grassroot Mns Non Tx		TotLbbyngGrassrootMnsNonTxGrp
Tot Lbby Expend Mns Lbbyng Non Tx		TotLbbyExpendMnsLbbyngNonTxGrp

Avg Lobbying Nontaxable Amount AvgLobbyingNontaxableAmountGrp

Field	Value	IRS element (for citing)
Current Year Minus3	$1,000,000	CurrentYearMinus3Amt
Current Year Minus2	$1,000,000	CurrentYearMinus2Amt
Current Year Minus1	$1,000,000	CurrentYearMinus1Amt
Current Year	$1,000,000	CurrentYearAmt
Total	$4,000,000	TotalAmt

Field	Value	IRS element (for citing)
Lobbying Ceiling	$6,000,000	LobbyingCeilingAmt

Avg Total Lobbying Expend AvgTotalLobbyingExpendGrp

Field	Value	IRS element (for citing)
Current Year Minus3	$259,559	CurrentYearMinus3Amt
Current Year Minus2	$291,378	CurrentYearMinus2Amt
Current Year Minus1	$198,306	CurrentYearMinus1Amt
Current Year	$439,604	CurrentYearAmt
Total	$1,188,847	TotalAmt

Avg Grassroots Nontaxable AvgGrassrootsNontaxableGrp

Field	Value	IRS element (for citing)
Current Year Minus3	$250,000	CurrentYearMinus3Amt
Current Year Minus2	$250,000	CurrentYearMinus2Amt
Current Year Minus1	$250,000	CurrentYearMinus1Amt
Current Year	$250,000	CurrentYearAmt
Total	$1,000,000	TotalAmt

Field	Value	IRS element (for citing)
Grassroots Ceiling	$1,500,000	GrassrootsCeilingAmt

Avg Grassroots Lobbying Expend AvgGrassrootsLobbyingExpendGrp

Field	Value	IRS element (for citing)
Current Year Minus3	$3,346	CurrentYearMinus3Amt
Current Year Minus2	$2,905	CurrentYearMinus2Amt
Current Year Minus1	$1,947	CurrentYearMinus1Amt
Current Year	$263	CurrentYearAmt
Total	$8,461	TotalAmt

Schedule D IRS990ScheduleD

Field	Value	IRS element (for citing)
Art Public Exhibition Amounts		ArtPublicExhibitionAmountsGrp
Held Works Art		HeldWorksArtGrp
CY Minus3 Yr Endwmt Fund		CYMinus3YrEndwmtFundGrp
CY Minus4 Yr Endwmt Fund		CYMinus4YrEndwmtFundGrp

Land LandGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$7,342,677	OtherCostOrOtherBasisAmt
Book Value	$7,342,677	BookValueAmt

Buildings BuildingsGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$48,003,287	OtherCostOrOtherBasisAmt
Depreciation	$14,507,866	DepreciationAmt
Book Value	$33,495,421	BookValueAmt

Leasehold Improvements LeaseholdImprovementsGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$773,776	OtherCostOrOtherBasisAmt
Depreciation	$637,110	DepreciationAmt
Book Value	$136,666	BookValueAmt

Equipment EquipmentGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$2,471,905	OtherCostOrOtherBasisAmt
Depreciation	$1,626,244	DepreciationAmt
Book Value	$845,661	BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$20,202,107	OtherCostOrOtherBasisAmt
Depreciation	$13,887,783	DepreciationAmt
Book Value	$6,314,324	BookValueAmt

Field	Value	IRS element (for citing)
Total Book Value Land Buildings	$48,134,749	TotalBookValueLandBuildingsAmt
Federal Income Tax Liability	$0	FederalIncomeTaxLiabilityAmt

Other Liabilities Org OtherLiabilitiesOrgGrp (3 entries)

DescDesc	AmtAmt
LIABILITY UNDER INTEREST RATE SWAP	$13,303,010
TAXABLE BOND PAYABLE	$16,377,714
DUE TO RELATED ORGANIZATION	$7,369,629

Field	Value	IRS element (for citing)
Total Liability	$37,050,353	TotalLiabilityAmt
Footnote Text	Yes (X)	FootnoteTextInd
Total Rev Etc Audited Fincl Stmt	$176,881,263	TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst	$16,856,803	NetUnrealizedGainsInvstAmt
Other Revenue	-$2,941,592	OtherRevenueAmt
Revenue Not Reported	$13,915,211	RevenueNotReportedAmt
Revenue Subtotal	$162,966,052	RevenueSubtotalAmt
Investment Expenses Not Incld	$79,584	InvestmentExpensesNotIncldAmt
Other Revenues Not Included	-$334,215	OtherRevenuesNotIncludedAmt
Revenue Not Reported Fincl Stmt	-$254,631	RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990	$162,711,421	TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt	$148,363,500	TotExpnsEtcAuditedFinclStmtAmt
Other Expenses Included	$334,215	OtherExpensesIncludedAmt
Expenses Not Reported	$334,215	ExpensesNotReportedAmt
Expenses Subtotal	$148,029,285	ExpensesSubtotalAmt
Investment Expenses Not Incld2	$79,584	InvestmentExpensesNotIncld2Amt
Expenses Not Rpt Fincl Stmt	$79,584	ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990	$148,108,869	TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail (4 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
PART X, LINE 2	IN ACCORDANCE WITH GAAP, THE ORGANIZATION MAY RECOGNIZE THE TAX BENEFIT FROM AN UNCERTAIN TAX POSITION ONLY IF IT IS MORE LIKELY THAN NOT THAT THE TAX POSITION WILL BE SUSTAINED ON EXAMINATION BY TAXING AUTHORITIES, BASED ON TECHNICAL MERITS OF THE POSITION. THE TAX BENEFITS RECOGNIZED IN THE CONSOLIDATED FINANCIAL STATEMENTS FROM SUCH A POSITION ARE MEASURED BASED ON THE LARGEST BENEFIT THAT HAS A GREATER THAN 50% LIKELIHOOD OF BEING REALIZED UPON ULTIMATE SETTLEMENT. THE ORGANIZATION BELIEVES THAT IT HAS APPROPRIATE SUPPORT FOR TAX POSITIONS TAKEN, AND THEREFORE, DOES NOT HAVE UNCERTAIN TAX POSITIONS THAT ARE MATERIAL TO THE CONSOLIDATED FINANCIAL STATEMENTS. GENERALLY, THE ORGANIZATION IS NO LONGER SUBJECT TO INCOME TAX EXAMINATIONS BY THE U.S. FEDERAL, STATE OR LOCAL TAX AUTHORITIES FOR YEARS PRIOR TO DECEMBER 31, 2016.
PART XI, LINE 2D	LOSS ON INTEREST RATE SWAP ($2,941,592)
PART XI, LINE 4B	RENTAL EXPENSES -$334,215
PART XII, LINE 2D	RENTAL EXPENSES $334,215

Schedule F IRS990ScheduleF

Field	Value	IRS element (for citing)
Grant Records Maintained	Yes (true)	GrantRecordsMaintainedInd

Account Activities Outside US AccountActivitiesOutsideUSGrp (18 entries)

RegionRegionTxt	Type Of Activities ConductedTypeOfActivitiesConductedTxt	Specific Services ProvidedSpecificServicesProvidedTxt	Region Total ExpendituresRegionTotalExpendituresAmt	OfficesOfficesCnt	EmployeeEmployeeCnt
East Asia and the Pacific	Program Services	SCIENTIFIC MEETING	$1,825,415
East Asia and the Pacific	Program Services	OUTREACH & EDUCATIONAL	$177,409
Europe (Including Iceland and Greenland)	Program Services	OUTREACH & EDUCATIONAL	$89,694
North America	Program Services	OUTREACH & EDUCATIONAL	$63,319	0	5
Russia and the Newly Independent States	Program Services	OUTREACH & EDUCATIONAL	$68,983
South America	Program Services	OUTREACH & EDUCATIONAL	$265,111
South Asia	Program Services	OUTREACH & EDUCATIONAL	$740,704
Sub-Saharan Africa	Program Services	OUTREACH & EDUCATIONAL	$790,191
Europe (Including Iceland and Greenland)	Grantmaking		$106,522
Central America and the Caribbean	Grantmaking		$2,212
East Asia and the Pacific	Grantmaking		$24,731
North America	Grantmaking		$5,045
South America	Grantmaking		$8,563
South Asia	Grantmaking		$27,926
Middle East and North Africa	Grantmaking		$1,000
Russia and the Newly Independent States	Grantmaking		$2,228
Sub-Saharan Africa	Grantmaking		$26,524
Central America and the Caribbean	Program Services	OUTREACH & EDUCATIONAL	$68,466

Field	Value	IRS element (for citing)
Subtotal Offices	0	SubtotalOfficesCnt
Subtotal Employees	5	SubtotalEmployeesCnt
Total Office	0	TotalOfficeCnt
Total Employee	5	TotalEmployeeCnt
Subtotal Spent	$4,225,577	SubtotalSpentAmt
Continuation Spent	$68,466	ContinuationSpentAmt
Total Spent	$4,294,043	TotalSpentAmt

Grants To Org Outside US GrantsToOrgOutsideUSGrp (2 entries)

RegionRegionTxt	Purpose Of GrantPurposeOfGrantTxt	Cash GrantCashGrantAmt	Manner Of Cash DisbursementMannerOfCashDisbursementTxt
Europe (Including Iceland and Greenland)	CONTRIBUTION	$79,625	WIRE
Europe (Including Iceland and Greenland)	CONTRIBUTION	$18,000	WIRE

Field	Value	IRS element (for citing)
Total501c3 Org	2	Total501c3OrgCnt

Foreign Individuals Grants ForeignIndividualsGrantsGrp (14 entries)

Type Of AssistanceTypeOfAssistanceTxt	RegionRegionTxt	RecipientRecipientCnt	Cash GrantCashGrantAmt	Manner Of Cash DisbursementMannerOfCashDisbursementTxt	Non Cash AssistanceNonCashAssistanceAmt	Description Of Non Cash AsstDescriptionOfNonCashAsstTxt	Valuation Method UsedValuationMethodUsedDesc
idea award	Central America and the Caribbean	1	$1,320	WIRE	$892	Travel	Book
idea award	East Asia and the Pacific	2	$2,625	WIRE	$3,106	travel	book
idea award	Europe (Including Iceland and Greenland)	1	$1,480	WIRE	$1,417	travel	book
idea award	North America	1	$1,320	WIRE	$725	travel	book
idea award	Russia and the Newly Independent States	1	$1,320	WIRE	$908	travel	book
idea award	South America	3	$3,960	WIRE	$4,603	travel	book
idea award	South Asia	8	$11,025	WIRE	$12,901	travel	book
idea award	Sub-Saharan Africa	7	$10,200	WIRE	$15,324	travel	book
Breakthrough Award	East Asia and the Pacific	19	$19,000	WIRE
Breakthrough Award	Europe (Including Iceland and Greenland)	6	$6,000	WIRE
Breakthrough Award	Middle East and North Africa	1	$1,000	WIRE
Breakthrough Award	North America	3	$3,000	WIRE
Breakthough Award	South Asia	4	$4,000	WIRE
Breakthrough Award	Sub-Saharan Africa	1	$1,000	WIRE

Field	Value	IRS element (for citing)
Transfer To Foreign Corp	Yes (true)	TransferToForeignCorpInd
Interest In Foreign Trust	false	InterestInForeignTrustInd
Foreign Corp Ownership	false	ForeignCorpOwnershipInd
Passive Foreign Investmest Co	false	PassiveForeignInvestmestCoInd
Foreign Partnership	false	ForeignPartnershipInd
Boycott Countries	Yes (true)	BoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	SCHEDULE F, PART I, LINE 1	FormAndLineReferenceDesc
Explanation	INTERNATIONAL DEVELOPMENT AND EDUCATION AWARDS (IDEA) - THE INTERNATIONAL DEVELOPMENT AND EDUCATION AWARDS PROVIDE SUPPORT FOR EARLY-CAREER ONCOLOGISTS IN DEVELOPING COUNTRIES TO LEARN ABOUT ONCOLOGY CARE AND RESEARCH BY ESTABLISHING STRONG RELATIONSHIPS WITH LEADING ASCO ONCOLOGISTS WHO SERVE AS SCIENTIFIC MENTORS TO EACH RECIPIENT. RECIPIENTS LEARN ABOUT QUALITY CANCER CARE AND RESEARCH BY ATTENDING THE ASCO ANNUAL MEETING AND VISITING THEIR MENTOR'S CANCER CENTER IN THE UNITED STATES AND CANADA. RECIPIENTS ARE EXPECTED TO SHARE THE KNOWLEDGE AND TRAINING THEY RECEIVE THROUGH THE PROGRAM WITH COLLEAGUES IN THEIR HOME COUNTRIES ONCE THEY RETURN. IDEAS ARE PROVIDED TO RECIPIENTS BASED ON MERIT THROUGH A PEER REVIEW PROCESS USING ESTABLISHED ELIGIBILITY CRITERIA. IDEA RECIPIENTS ARE REQUIRED TO AGREE TO TERMS AND CONDITIONS APPLICABLE TO THE IDEA, ARE REQUIRED TO COMMUNICATE WITH THEIR MENTORS, TO ATTEND ALL IDEA-RELATED EVENTS, TO SUBMIT EVALUATIONS AFTER THE ANNUAL MEETING AND MENTOR SITE VISIT, AND TO SUBMIT ONE-YEAR REPORTS. BREAKTHROUGH SUMMIT AND MERIT AWARDS These awards recognize oncology fellows, junior faculty, and trainees for their valuable research in clinical cancer treatment and technology innovations in cancer care. Awardees presented their research at the inaugural ASCO Breakthrough: A Global Summit for Oncology meeting held during October 11-13, 2019, in Bangkok, Thailand. Abstract Awards supported the first authors of the 50 highest-rated abstracts selected for presentation at the ASCO Breakthrough Summit. Merit Awards recognized the quality and scientific merit of research submitted by oncology fellows and trainees to an ASCO meeting.	ExplanationTxt

Schedule I IRS990ScheduleI

Field	Value	IRS element (for citing)
Grant Records Maintained	Yes (true)	GrantRecordsMaintainedInd

Recipient Table RecipientTable (11 entries)

Address Line1USAddress/AddressLine1Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	Recipient EINRecipientEIN	IRC SectionIRCSectionDesc	Cash GrantCashGrantAmt	Purpose Of GrantPurposeOfGrantTxt
Conquer Cancer Foundation of ASCO
2318 Mill Rd Ste 800	Alexandria	VA	22314	311667995	501(c)(3)	$1,764,000	Contribution
Banner Health
2901 N Central Ave	Phoenix	AZ	85012	450233470	501(c)(3)	$60,000	Contribution
Brigham & Women's Hospital
75 Francis St Tower 1	Boston	MA	02215	042312909	501(c)(3)	$167,500	Contribution
Dana Farber Cancer Institute
450 Brookline Avenue	Boston	MA	02215	042263040	501(c)(3)	$25,000	Contribution
Duke University Medical Center
2424 Erwin Rd Suite 601	Durham	NC	27705	560532129	501(c)(3)	$6,667	Contribution
Friends of Cancer Research
1800 M Street NW	Washington	DC	20036	521983273	501(c)(3)	$32,000	Contribution
Regents of the University of Michigan
300 N Ingalls St	Ann Arbor	MI	48109	386006309	501(C)(3)	$40,000	contribution
Susan G Komen Foundation
5005 LBJ Freeway Ste 250	Dallas	TX	75244	751835298	501(c)(3)	$10,000	Contribution
SARAH CANNON RESEARCH INSTITUTE
ONE PARK PLAZA	NASHVILLE	FL	32703	201557751	LLC	$109,166	CONTRIBUTION
Health Volunteers Oversees
1900 L Street NW	Washington	DC	20036	521485477	501(c)(3)	$10,000	CONTRIBUTION
National Coalition for Cancer Survivorship
8455 Colesville Rd	Silver Springs	MD	20910	850357897	501(c)(3)	$10,000	CONTRIBUTION

Field	Value	IRS element (for citing)
Total501c3 Org	10	Total501c3OrgCnt
Total Other Org	1	TotalOtherOrgCnt

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDesc

ExplanationExplanationTxt

SCHEDULE I, PART I, LINE 1

ASCO provides assistance to 501(c)(3) organizations that serve the cancer community.

SCHEDULE I, PART I, LINE 2

ASCO PROVIDES ASSISTANCE TO ORGANIZATIONS THAT SERVE THE CANCER CARE COMMUNITY. THE MAJORITY OF THESE GRANTS ARE MADE TO OTHER 501(C)(3) ORGANIZATIONS. THE GRANT MADE TO A NON-501(C)(3) ORGANIZATION WAS MADE PURSUANT TO A WRITTEN AGREEMENT THAT REQUIRED THE GRANT FUNDS TO BE USED FOR SPECIFIC EDUCATIONAL AND CHARITABLE PROJECTS, THAT THE GRANTEE RETURN ANY PORTION OF THE GRANT FUNDS THAT WERE NOT USED FOR SUCH PROJECTS, AND THAT THE GRANTEE PROVIDE ANNUAL NARRATIVE AND FINANCIAL REPORTS TO ASCO REGARDING GRANTEE'S USE OF THE GRANT FUNDS.

Schedule J IRS990ScheduleJ

Field	Value	IRS element (for citing)
Compensation Committee	Yes (X)	CompensationCommitteeInd
Independent Consultant	Yes (X)	IndependentConsultantInd
Form990 Of Other Organizations	Yes (X)	Form990OfOtherOrganizationsInd
Written Employment Contract	Yes (X)	WrittenEmploymentContractInd
Compensation Survey	Yes (X)	CompensationSurveyInd
Board Or Committee Approval	Yes (X)	BoardOrCommitteeApprovalInd
Severance Payment	false	SeverancePaymentInd
Supplemental Nonqual Rtr Plan	false	SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm	false	EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng Org	false	CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs	false	CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng Org	false	CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs	false	CompBsdNetEarnsRltdOrgsInd
Any Non Fixed Payments	Yes (true)	AnyNonFixedPaymentsInd
Initial Contract Exception	false	InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (19 entries)

TitleTitleTxt	Base Compensation Filing OrgBaseCompensationFilingOrgAmt	Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt	Bonus Filing OrganizationBonusFilingOrganizationAmount	Bonus Related OrganizationsBonusRelatedOrganizationsAmt	Other Compensation Filing OrgOtherCompensationFilingOrgAmt	Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt	Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt	Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt	Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt	Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt	Total Compensation Filing OrgTotalCompensationFilingOrgAmt	Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt	Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt	Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
Clifford HudisMD
CEO, NON-VOTING DIRECTOR	$818,627	$0	$79,567	$0	$0	$0	$21,000	$0	$3,233	$0	$922,427	$0	$0	$0
Richard Schilsky MD
EVP, Chief Medical Officer	$569,039	$0	$7,500	$0	$250	$0	$21,000	$0	$16,756	$0	$614,545	$0	$0	$0
Dina Michels Esq
EVP, CHIEF LEGAL OFFICER	$574,231	$0	$7,500	$0	$0	$0	$21,000	$0	$18,055	$0	$620,786	$0	$0	$0
Linda Jensen MBA
EVP, Chief Financial Officer	$394,424	$0	$7,500	$0	$0	$0	$21,000	$0	$17,536	$0	$440,460	$0	$0	$0
Nancy Daly MS MPH
EVP, CHIEF PHILANTHROPIC OFF.	$380,173	$0	$7,500	$0	$0	$0	$21,000	$0	$17,537	$0	$426,210	$0	$0	$0
Jamie Von Roenn MD
VP, Education	$384,423	$0	$7,500	$0	$250	$0	$21,000	$0	$10,472	$0	$423,645	$0	$0	$0
Bernie Khoo
VP, INFORMATION TECHNOLOGY	$424,423	$0	$5,000	$0	$0	$0	$21,000	$0	$22,541	$0	$472,964	$0	$0	$0
Stephen Grubbs MD
VP, Clinical Affairs	$384,423	$0	$7,500	$0	$0	$0	$21,000	$0	$16,756	$0	$429,679	$0	$0	$0
Robert Miller MD
MEDICAL DIRECTOR, CANCERLINQ	$355,869	$0	$6,000	$0	$250	$0	$21,000	$0	$22,811	$0	$405,930	$0	$0	$0
Deborah Kamin RN PHD
VP, POLICY AND ADVOCACY	$299,423	$0	$7,500	$0	$1,000	$0	$21,000	$0	$17,537	$0	$346,460	$0	$0	$0
Kristin Ludwig
VP, MKTG. & Communications	$298,692	$0	$7,500	$0	$0	$0	$21,000	$0	$3,233	$0	$330,425	$0	$0	$0
Krista Barnes
VP, Member Services	$249,746	$0	$7,500	$0	$250	$0	$18,664	$0	$22,811	$0	$298,971	$0	$0	$0
Amanda Davis-Aitken
VP, Meeting Services	$247,692	$0	$7,500	$0	$0	$0	$18,577	$0	$10,079	$0	$283,848	$0	$0	$0
CORY WIEGERT
EVP, CEO CANCERLINQ	$414,423	$0	$0	$0	$0	$0	$28,618	$0	$18,956	$0	$461,997	$0	$0	$0
CARMEN JACKSON
COO, CANCERLINQ	$280,288	$0	$34,200	$0	$250	$0	$21,000	$0	$22,811	$0	$358,549	$0	$0	$0
ANIL NAIR
CTO, CANCERLINQ	$270,096	$0	$21,200	$0	$250	$0	$20,257	$0	$16,044	$0	$327,847	$0	$0	$0
DAVID SAMPSON
VP, JOURNALS & PUBLISHER	$273,461	$0	$7,500	$0	$250	$0	$20,510	$0	$22,811	$0	$324,532	$0	$0	$0
CHRISTOPHER MERLAN
EVP, CHIEF DIGITAL OFFICER	$115,269	$0	$20,000	$0	$10,000	$0	$0	$0	$9,338	$0	$154,607	$0	$0	$0
CAROLYN WHITEHEAD
DIVISION DIR., CONQUER CANCER	$257,212	$0	$37,200	$0	$0	$0	$19,291	$0	$3,233	$0	$316,936	$0	$0	$0

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	Part I, Line 7:	FormAndLineReferenceDesc
Explanation	PERFORMANCE-BASED BONUS PAYMENTS CAN BE MADE TO SOME EMPLOYEES LISTED ON SCHEDULE J AND INCLUDED AS PART OF THE TOTAL COMPENSATION. THE BONUS PAYMENTS ARE NOT ON A FIXED BASIS BUT RATHER ARE BASED ON PERFORMANCE AND DETERMINED BY THE CEO WITH REVIEW AND APPROVAL BY THE COMPENSATION COMMITTEE OF THE BOARD, WHERE APPROPRIATE.	ExplanationTxt

Schedule K IRS990ScheduleK

Tax Exempt Bonds Issues TaxExemptBondsIssuesGrp

Field	Value	IRS element (for citing)
Bond Reference	A	BondReferenceCd

Issuer Name IssuerName

Field	Value	IRS element (for citing)
Business Name Line1	INDUSTRIAL DEVELOPMENT AUTHORITYCITY OF ALEXANDRI	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
Bond Issuer EIN	521381432	BondIssuerEIN
CUSIP	01530lad2	CUSIPNum
Bond Issued	2012-08-01	BondIssuedDt
Issue Price	$38,400,000	IssuePriceAmt
Purpose	Buy/Buildout 5 floors HQ building	PurposeDesc
Defeased	false	DefeasedInd
On Behalf Of Issuer	false	OnBehalfOfIssuerInd
Pool Financing	false	PoolFinancingInd

Tax Exempt Bonds Proceeds TaxExemptBondsProceedsGrp

Field	Value	IRS element (for citing)
Bond Reference	A	BondReferenceCd
Retired	$0	RetiredAmt
Bond Defeased	$0	BondDefeasedAmt
Total Proceeds	$38,400,000	TotalProceedsAmt
In Reserve Fund	$0	InReserveFundAmt
Capitalized Interest	$0	CapitalizedInterestAmt
Refunding Escrow	$0	RefundingEscrowAmt
Issuance Costs From Proceeds	$0	IssuanceCostsFromProceedsAmt
Credit Enhancement	$0	CreditEnhancementAmt
Working Capital Expenditures	$0	WorkingCapitalExpendituresAmt
Capital Expenditures	$38,400,000	CapitalExpendituresAmt
Other Spent Proceeds	$0	OtherSpentProceedsAmt
Unspent	$0	UnspentAmt
Substantial Completion	2008	SubstantialCompletionYr
Refunding Tax Exempt Bonds	Yes (true)	RefundingTaxExemptBondsInd
Refunding Taxable Bonds	false	RefundingTaxableBondsInd
Final Allocation Made	Yes (true)	FinalAllocationMadeInd
Adequate Books And Rec Maint	Yes (true)	AdequateBooksAndRecMaintInd

Tax Exempt Bonds Private Bus Use TaxExemptBondsPrivateBusUseGrp

Field	Value	IRS element (for citing)
Bond Reference	A	BondReferenceCd
Owning Bond Financed Property	false	OwningBondFinancedPropertyInd
Any Lease Arrangements	false	AnyLeaseArrangementsInd
Mgmt Contract Bond Fincd Prop	Yes (true)	MgmtContractBondFincdPropInd
Engage Bond Counsel Contracts	Yes (true)	EngageBondCounselContractsInd
Any Research Agreements	false	AnyResearchAgreementsInd
Private Bus Use By Others	0	PrivateBusUseByOthersPct
Private Bus Concerning UBI	0.04590	PrivateBusConcerningUBIPct
Total Private Business Use	0.04590	TotalPrivateBusinessUsePct
Bond Iss Meet Prvt Sec Pymt Test	false	BondIssMeetPrvtSecPymtTestInd
Change In Use Bond Financed Prop	false	ChangeInUseBondFinancedPropInd
Remedial Action Taken	false	RemedialActionTakenInd
Procs Nonqualified Bond Remdtd	Yes (true)	ProcsNonqualifiedBondRemdtdInd

Tax Exempt Bonds Arbitrage TaxExemptBondsArbitrageGrp

Field	Value	IRS element (for citing)
Bond Reference	A	BondReferenceCd
Form8038 T Filed	false	Form8038TFiledInd
Rebate Not Due Yet	false	RebateNotDueYetInd
Exception To Rebate	false	ExceptionToRebateInd
No Rebate Due	Yes (true)	NoRebateDueInd
Variable Rate Issue	Yes (true)	VariableRateIssueInd
Hedge Identified In Bks And Rec	Yes (true)	HedgeIdentifiedInBksAndRecInd

Hedge Provider Name HedgeProviderName

Field	Value	IRS element (for citing)
Business Name Line1	FMS WERTMANAGEMENT	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
Term Of Hedge	30.	TermOfHedgePct
Superintegrated Hedge	false	SuperintegratedHedgeInd
Hedge Terminated	false	HedgeTerminatedInd
Gross Proceeds Invested In GIC	false	GrossProceedsInvestedInGICInd

GIC Provider Name GICProviderName

Field	Value	IRS element (for citing)
Business Name Line1	0	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
Written Proc To Monitor Reqs	Yes (true)	WrittenProcToMonitorReqsInd

Procedures Corrective Action ProceduresCorrectiveActionGrp

Field	Value	IRS element (for citing)
Bond Reference	A	BondReferenceCd
Procedures Corrective Action	Yes (true)	ProceduresCorrectiveActionInd

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDesc

ExplanationExplanationTxt

PART IV, QUESTION 3

ASCO HAS AN INTEREST RATE SWAP AGREEMENT WITH FMS WERTMANAGEMENTBANK THROUGH 2038. ASCO MAKES FIXED INTEREST PAYMENTS AT A 3.587% RATE. VARIABLE SWAP PAYMENTS, BASED ON ONE-MONTH LIBOR, RECEIVED FROM THE SWAP COUNTERPARTY ARE USED TO MAKE THE VARIABLE INTEREST PAYMENTS AS THEY COME DUE. THIS INTEREST RATE SWAP AGREEMENT QUALIFIES AS A DERIVATIVE INSTRUMENT AND IS USED TO MITIGATE THE EFFECT OF INTEREST RATE FLUCTUATIONS.

PART VI, QUESTION 2C

THE LATEST REBATE COMPUTATION DATE FOR THE REPORTED BOND ISSUE WAS OCTOBER 2, 2019.

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (19 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
FORM 990, PART III, LINE 1	ASCO IS A PROFESSIONAL ONCOLOGY SOCIETY COMMITTED TO CONQUERING CANCER THROUGH RESEARCH, EDUCATION, AND PROMOTION OF THE HIGHEST QUALITY AND EQUITABLE PATIENT CARE. ASCO'S VISION IS A WORLD WHERE CANCER IS PREVENTED OR CURED, AND EVERY SURVIVOR IS HEALTHY. ASCO PROMOTES AND PROVIDES FOR: - LIFELONG LEARNING FOR ONCOLOGY PROFESSIONALS, - CANCER RESEARCH, - AN IMPROVED ENVIRONMENT FOR ONCOLOGY PRACTICE, - ACCESS TO QUALITY CANCER CARE, - A GLOBAL NETWORK OF ONCOLOGY EXPERTISE, AND - EDUCATED AND INFORMED PATIENTS WITH CANCER.
FORM 990, PART III, LINE 4A	SCIENTIFIC AND MEDICAL EDUCATION: ASCO PROVIDES SCIENTIFIC AND EDUCATIONAL PROGRAMS AND CONTENT ON A BROAD RANGE OF ONCOLOGY-RELATED TOPICS IN A VARIETY OF FORMATS. WORKING WITH VOLUNTEER ASCO MEMBERS, ASCO PLANS AND PRESENTS LIVE MEETINGS ON THE LATEST RESEARCH AND ADVANCES IN THE FIELD OF CLINICAL ONCOLOGY. THE ONCOLOGY-SPECIFIC INFORMATION PRESENTED AT THESE MEETINGS ENHANCES KNOWLEDGE ABOUT TREATING CANCER AND CARING FOR CANCER PATIENTS. THE ASCO ANNUAL MEETING IS THE WORLD'S PREMIER SCIENTIFIC AND EDUCATIONAL MEETING IN THE ONCOLOGY COMMUNITY. THE THEMATIC MEETINGS, PRESENTED OR CO-SPONSORED BY ASCO, PROVIDE OPPORTUNITIES FOR FOCUSED EDUCATIONAL AND SCIENTIFIC SESSIONS ON SPECIFIC TYPES OF CANCERS. ASCO'S PROGRAMS ARE DESIGNED TO SERVE THE DIVERSE NEEDS OF ONCOLOGY PRACTITIONERS WORLDWIDE TO ASSIST THEM IN DELIVERING HIGH QUALITY CANCER CARE AND CONDUCTING CLINICAL RESEARCH THROUGH THE CONTINUUM OF THEIR CAREERS. PROGRAMS ADDRESS THE MODERN-DAY PRACTICE OF ONCOLOGY FOR ALL LEVELS OF PRACTITIONERS INCLUDING ONCOLOGY FELLOWS, JUNIOR FACULTY MEMBERS, ONCOLOGY PROGRAM DIRECTORS, ETC. WORKING WITH VOLUNTEER ASCO MEMBERS, ASCO PLANS, IMPLEMENTS AND EVALUATES CONTINUING MEDICAL EDUCATION (CME) TO SUPPORT THE CONTINUED EDUCATION OF ONCOLOGISTS AND OTHER MEMBERS OF THE CANCER CARE TEAM TO ENABLE THEM TO BETTER MEET THE PREVENTION, DIAGNOSIS AND TREATMENT NEEDS OF THEIR PATIENTS. CURRENTLY, ASCO HOLDS THE STATUS OF ACCREDITATION WITH COMMENDATION FROM THE ACCREDITATION COUNCIL FOR CME FOR ASCO'S CME PROGRAM. ASCO MAKES MUCH OF THE CONTENT FROM ITS MEETINGS AND OTHER EDUCATIONAL AND SCIENTIFIC CONTENT PUBLICLY AVAILABLE THROUGH TWO ASCO WEBSITES: WWW.ASCO.ORG AND WWW.CANCER.NET. ADDITIONALLY, ASCO MAKES SCIENTIFIC AND EDUCATIONAL MATERIALS AVAILABLE THROUGH A VARIETY OF CHANNELS, INCLUDING BOOKS, DVDS, VIRTUAL MEETINGS, PODCASTS AND PUBLIC FORUMS. HIGHLIGHTS OF THE 2019 ACTIVITIES INCLUDE: OVER 42,500 PEOPLE ATTENDED THE 2019 ASCO ANNUAL MEETING, INCLUDING PHYSICIANS, NURSES, CAREGIVERS, PATIENTS, AND PATIENT ADVOCATES. APPROXIMATELY 40% OF THE ATTENDEES AT THE 2019 ASCO ANNUAL MEETING WERE INTERNATIONAL ATTENDEES. THE 2019 ANNUAL MEETING FEATURED OVER 265 EDUCATIONAL AND SCIENTIFIC SESSIONS AND OVER 5,000 ABSTRACTS WERE PRESENTED OR PUBLISHED. NEARLY 5,000 PRESENTATIONS WERE CAPTURED IN AUDIO AND VIDEO TO BE MADE AVAILABLE ELECTRONICALLY. IN ADDITION TO THE ASCO ANNUAL MEETING, ASCO SPONSORS OR CO-SPONSORS MORE THAN 40 EDUCATIONAL AND SCIENTIFIC SYMPOSIA, WORKSHOPS, AND COURSES INSIDE AND OUTSIDE THE UNITED STATES ON A WIDE VARIETY OF CANCER-RELATED TOPICS TO IMPROVE ONCOLOGY CARE WORLDWIDE. THESE MEETINGS INCLUDE: - BEST OF ASCO - PALLIATIVE AND SUPPORTIVE CARE IN ONCOLOGY SYMPOSIUM - QUALITY CARE SYMPOSIUM - GASTROINTESTINAL (GI) CANCERS SYMPOSIUM - GENITOURINARY (GU) CANCERS SYMPOSIUM - CLINICAL IMMUNO-ONCOLOGY SYMPOSIUM INTERNATIONAL AFFAIRS MEETINGS AND COURSES: - ASCO BREAKTHROUGH - BEST OF ASCO INTERNATIONAL - JOINT SYMPOSIA - ADVANCED CANCER COURSES - MULTIDISCIPLINARY CANCER MANAGEMENT COURSES ASCO PUBLISHES DAILY NEWS PRODUCTS FOR EACH OF ITS MAJOR MEETINGS (E.G.,ASCO ANNUAL MEETING, GI CANCERS SYMOSIUM, GU CANCERS SYMOSIUM). THESE PRODUCTS INCLUDE PRINT NEWSPAPERS THAT ARE DISTRIBUTED ONSITE TO ALL ATTENDEES AND PUBLICLY AVAILABLE ONLINE. THE DAILY NEWS PRODUCTS PROVIDE EDITORIAL COVERAGE OF KEY MEETING SESSIONS, COMMENTARIES BY EXPERTS IN VARIOUS SUBSPECIALTIES, INFORMATION ABOUT ASCO PRODUCTS AND RESOURCES, PROFILES OF GRANT AND AWARD WINNERS, AND OTHER TOPICS OF INTEREST TO ASCO MEMBERS AND MEETING ATTENDEES FROM AROUND THE WORLD.
FORM 990, PART III, LINE 4B	QUALITY OF CARE: ASCO PRODUCES EVIDENCE-BASED GUIDELINES, DEVELOPS AND VALIDATES QUALITY MEASURES IN ONCOLOGY, AND CONDUCTS QUALITY MEASUREMENT, IMPROVEMENT, AND CERTIFICATION ACTIVITIES PROGRAMS INCLUDE: - CANCERLINQ. THIS BIG-DATA PLATFORM DELIVERS VALUABLE INSIGHTS AND TOOLS TO IMPROVE PATIENT CARE BY COLLECTING AND ANALYZING REAL-WORLD CANCER DATA FROM HEALTHCARE IT SYSTEMS ACROSS THE COUNTY. THE CANCERLINQ DATABASE REFLECTS CANCER CARE IN ALL ITS REAL-WORLD VARIABILITY - ALLOWING CLINICIANS TO LEARN FROM THE EXPERIENCE OF EVERY PATIENT. - QUALITY ONCOLOGY PRACTICE INITIATIVE (QOPI). A QUALITY ASSESSMENT AND IMPROVEMENT PROGRAM FOR OUTPATIENT MEDICAL ONCOLOGY AND HEMATOLOGY-ONCOLOGY PRACTICES: QOPI PROVIDES A WEB-BASED DATA COLLECTION TOOL THAT ALLOWS PRACTICE STAFF TO 1) REPORT ON VARIOUS CANCER CARE QUALITY MEASURES, 2) RECEIVE ANALYZED DATA ON PRACTICE PERFORMANCE, AND 3) COMPARE PERFORMANCE AGAINST THEIR PEERS FOR DATA-DRIVEN IMPROVEMENT ACTIVITIES. QOPI CERTIFICATION PROGRAM. THE QOPI CERTIFICATION PROGRAM PROVIDES A THREE-YEAR CERTIFICATE RECOGNIZING HIGH QUALITY CARE FOR OUTPATIENT HEMATOLOGY-ONCOLOGY PRACTICES. THE CERTIFICATION PROCESS CREATES A CULTURE OF EXCELLENCE AND SELF-EXAMINATION THAT HELPS PRACTICES DELIVER THE BEST CARE TO THEIR PATIENTS - CLINICAL PRACTICE GUIDELINES AND UPDATES. ASCO HAS PUBLISHED MORE THAN 50 PRACTICE GUIDELINES, ENDORSEMENTS, AND PROVISIONAL CLINICAL OPINIONS (PCO'S) ADDRESSING A WIDE RANGE OF CANCER TREATMENT, DIAGNOSIS, AND MANAGEMENT ISSUES. - QOPI REPORTING REGISTRY. ASCO PROVIDES A QUALIFIED CLINICAL DATA REGISTRY TO HELP MEMBERS SATISFY THE FEDERAL GOVERNMENTS MIPS REPORTING REQUIREMENTS. - QUALITY TRAINING PROGRAM. ASCOS QUALITY TRAINING PROGRAM IS DESIGNED TO HELP PRACTICES IMPROVE CLINICAL CARE AND OPERATIONAL PERFORMANCE. IN ADDITION, ASCO OFFERS PRACTICE MANAGEMENT PROGRAMS AND PRODUCTS DESIGNED TO SUPPORT PRACTICE HEALTH TO ENABLE PRACTICES TO DELIVER HIGH QUALITY CARE. THESE RESOURCES INCLUDE: - PRACTICE.NET. THIS LEARNING NETWORK IS FOCUSED ON HELPING PRACTICES IMPROVE THEIR BUSINESS OPERATIONS - FDA ALERTS. ASCO PARTNERS WITH THE FDA TO PROVIDE ITS MEMBERS TIMELY SAFETY ALERTS AND NOTICES OF NEWLY APPROVED CANCER THERAPIES. - PRACTICE EVALUATION. ASCO PROVIDES BOTH OPERATIONAL AND CLINICAL EVALUATION SERVICES INCLUDING READINESS AND PRACTICE OPERATIONS ASSESSMENTS, ANALYTICS, TRIAGE PATHWAYS, NURSE TRAINING SUPPORT, AND A VALUE BASED CARE DELIVERY MODEL.
FORM 990, PART III, LINE 4C	SCIENTIFIC PUBLICATIONS: ASCO PRODUCES A NUMBER OF PROFESSIONAL PUBLICATIONS FOCUSED ON CLINICAL ONCOLOGY. o ASCO PUBLISHES SEVERAL PEER-REVIEWED SCIENTIFIC JOURNALS: o JOURNAL OF CLINICAL ONCOLOGY (JCO) IS A HIGHLY REGARDED, PEER-REVIEWED JOURNAL THAT DISSEMINATES QUALITY ARTICLES ON SIGNIFICANT CLINICAL ONCOLOGY RESEARCH IN PRINT AND ELECTRONIC FORMATS. o JCO ONCOLOGY PRACTICE (JCO OP) INCLUDES ORIGINAL RESEARCH AND PERSPECTIVES ON CLINICAL AND ADMINISTRATIVE MANAGEMENT ADDRESSING THE PRACTICE OF ONCOLOGY, WHICH ARE EDITED BY ONCOLOGISTS. o JCO GLOBAL ONCOLOGY (JCO GO) IS AN ONLINE ONLY, OPEN ACCESS JOURNAL FOCUSED ON CANCER CARE, RESEARCH AND CARE DELIVERY ISSUES UNIQUE TO COUNTRIES AND SETTINGS WITH LIMITED HEALTHCARE RESOURCES. o JCO CLINICAL CANCER INFORMATICS (JCO CCI) IS AN ONLINE-ONLY INTERDISCIPLINARY JOURNAL PUBLISHING CLINICALLY RELEVANT RESEARCH BASED ON BIOMEDICAL INFORMATICS METHODS AND PROCESSES APPLIED TO CANCER-RELATED DATA, INFORMATION AND IMAGES. o JCO PRECISION ONCOLOGY (JCO PO) IS A PEER-REVIEWED, ONLINE-ONLY, ARTICLE BASED JOURNAL PUBLISHING ORIGINAL RESEARCH, REPORTS, OPINIONS AND REVIEWS THAT ADVANCE THE SCIENCE AND PRACTICE OF PRECISION ONCOLOGY AND DEFINE GENOMICS-DRIVEN CLINICAL CARE OF PATIENTS WITH CANCER. ASCO PUBLISHES THE ANNUAL CLINICAL CANCER ADVANCES (CCA) REPORT. THIS PUBLICLY-AVAILABLE REPORT ESTABLISHES THE MOST IMPORTANT CLINICAL ADVANCES IN ONCOLOGY EACH YEAR. THE REPORT SERVES TO DOCUMENT THE PROGRESS BEING MADE AGAINST CANCER THROUGH CLINICAL RESEARCH, PARTICULARLY THROUGH FEDERALLY FUNDED RESEARCH. ASCO IS INVOLVED IN THE PRODUCTION OF THE ASCO POST, A TRADE PUBLICATION. WHILE NOT OWNED OR PUBLISHED BY ASCO, THIS TRADE COVERS NEWS AND INFORMATION OF INTEREST TO THE PROFESSIONAL ONCOLOGY COMMUNITY AND ASCO PROVIDES ASCO-SPECIFIC CONTENT FOR INCLUSION.
FORM 990, PART III, LINE 4D	MEMBER SERVICES: ASCO WORKS TO SUPPORT AND EDUCATE ITS MORE THAN 45,000 MEMBERS THROUGH ITS DAILY ACTIVITIES, INCLUDING PROCESSING NEW MEMBERSHIP APPLICATIONS AND MEMBER DUES, PHONE AND EMAIL COMMUNICATIONS, RESEARCHING AND FULFILLING MEMBER REQUESTS, MAINTAINING THE INTEGRITY OF MEMBER DATA, AND NEW MEMBER RECRUITMENT AND RETENTION EFFORTS. ASCO CONNECTION IS THE OFFICIAL MEMBER MAGAZINE FOR AND ABOUT MEMBERS OF ASCO AND THE PRIMARY SOURCE OF INFORMATION ABOUT ASCO'S PROGRAMS AND SERVICES. ALONG WITH ITS COMPANION PROFESSIONAL NETWORKING SITE, ASCOCONNECTION.ORG, ASCO CONNECTION PROMOTES OPPORTUNITIES FOR INTERACTION BETWEEN ASCO AND ITS MEMBERS, AND MEMBERS AND THEIR COLLEAGUES TO FACILITATE THE DISSEMINATION OF INFORMATION RELATING TO CLINICAL RESEARCH, BEST PRACTICES STANDARDS, AND TREATMENT OF PATIENTS. ASCOCONNECTION.ORG FEATURES COMMENTARY BY LEADERS IN THE FIELD, DISCUSSION FORUMS, ONLINE EXCLUSIVES AND COMMENT-ENABLED ARTICLES FROM THE MEMBER MAGAZINE, AS WELL AS OPPORTUNITIES TO CREATE GROUPS. EXPENSES $9,585,095. INCLUDING GRANTS OF $408,333. REVENUE $7,504,263. RESEARCH: ASCO IS ACTIVELY ENGAGED IN THE SUPPORT, PROMOTION AND CONDUCT OF CLINICAL CANCER RESEARCH. RESEARCH RELATED ACTIVITIES INCLUDE: o RESEARCH COMMUNITY FORUM (RCF). ASCO PROVIDES A NETWORK (ONLINE AND IN-PERSON) FOR ALL MEMBERS OF THE ONCOLOGY RESEARCH COMMUNITY TO PROMOTE BEST PRACTICES FOR CONDUCTING AND MANAGING CLINICAL RESEARCH. o ORIGINAL RESEARCH. ASCO CONDUCTS RESEARCH TO DEVELOP EVIDENCE THAT INFORMS PATIENT CARE, PUBLIC POLICY, AND EDUCATION. RESEARCH INCLUDES SURVEYS, OBSERVATIONAL STUDIES AND CLINICAL TRIALS. o TAPUR. ASCO IS CONDUCTING A CLINICAL TRIAL TO TEST THE SAFETY AND EFFICACY OF FDA-APPROVED, TARGETED ANTICANCER DRUGS IN OTHER CANCER TYPES FOR PATIENTS WITH THE SAME GENOMIC ALTERATION. o SCIENTIFIC/RESEARCH COLLABORATIONS. ASCO WORKS WITH OTHER STAKEHOLDERS IN THE COMMUNITY, INCLUDING GOVERNMENT AGENCIES, PATIENT ADVOCACY GROUPS, AND OTHER PROFESSIONAL MEDICAL SOCIETIES TO SUPPORT AND PROMOTE RESEARCH THAT INFORMS EVIDENCE-BASED PATIENT CARE. o ASCO-FDA SCIENTIFIC COLLABORATIONS. ASCO JOINTLY HOSTS PUBLIC WORKSHOPS WITH THE FDA TO PROVIDE STAKEHOLDERS AN OPPORTUNITY TO DISCUSS EMERGING ISSUES IN RESEARCH AND FDA REVIEW OF NEW THERAPIES. o DATA/RESEARCH REQUESTS. ASCO REVIEWS 3RD PARTY REQUESTS TO CONDUCT RESEARCH USING THE SOCIETYS PROPRIETARY ASSETS. RESEARCH GRANTS AND AWARDS. ASCO MAKES GRANTS TO CONQUER CANCER, THE ASCO FOUNDATION, WHICH PROVIDES RESEARCH GRANTS AND AWARDS TO SUPPORT THE INDEPENDENT RESEARCH INITIATIVES OF CLINICAL INVESTIGATORS AT ALL LEVELS OF THEIR CAREERS. EXPENSES $9,003,637. INCLUDING GRANTS OF $1,350,000. REVENUE $5,772,767. CANCER POLICY AND ADVOCACY: ASCOS POLICY AND ADVOCACY WORK FOCUSES ON THE ISSUES OF ACCESS TO AND DELIVERY OF HIGH-QUALITY AND EQUITABLE CANCER CARE FOR CANCER PATIENTS. WORKING WITH VOLUNTEER ASCO MEMBERS, THE SOCIETY ENGAGES WITH THE ADMINISTRATION, CONGRESS, AND STATE LAW MAKERS TO ADDRESSES POLICY ISSUES OF CRITICAL IMPORTANCE TO THE PRACTICE OF ONCOLOGY AND PATIENT CARE. ASCO'S POLICY AND ADVOCACY PROGRAMS COVER A BROAD SPECTRUM OF ISSUES, INCLUDING CLINICAL CANCER RESEARCH, HEALTH INSURANCE, CLINICAL PRACTICE, WORKFORCE, DISPARITIES, COST/ACCESS, CANCER SURVIVORSHIP, AND CANCER PREVENTION AND CONTROL. ASCO PROVIDES EDUCATIONAL WORKSHOPS AND MATERIALS, LEGAL ANALYSIS, DEVELOPMENT OF FORMAL COMMENTS AND TESTIMONY, ADVOCACY, HOTLINES, TOOLS, AND SPECIAL STUDIES ON CRITICAL ISSUES FOR THE CANCER COMMUNITY. ASCO ROUTINLEY COLLABORATES WITH OTHERS IN THE COMMUNITY TO ADVANCE COMMON GOALS RELATED TO ACCESS TO AND DELIVERY OF HIGH-QUALITY CANCER CARE. o STATE/REGIONAL AFFILIATE PROGRAM. THE 46 STATE/REGIONAL AFFILIATES INTERACT WITH ASCO THROUGH THE STATE AFFILIATE COUNCIL, WHERE EACH SOCIETY HAS A VOTING REPRESENTATIVE CHARGED WITH SERVING AS THE BRIDGE BETWEEN THE SOCIETY AND ASCO. AFFILIATES HAVE ACCESS TO A NUMBER OF PROGRAMS INCLUDING STATE SOCIETY MEMBERSHIP RECRUITMENT AND RETENTION ASSISTANCE, LEADERSHIP TRAINING, FEDERAL-LEVEL ADVOCACY SUPPORT, EDUCATION AND RESOURCES ON PRACTICE-RELATED ISSUES, AND A WEBSITE DEVELOPMENT TOOL. ORIGINAL DATA COLLECTION. ASCO CONDUCTS STUDIES AND ANALYSES TO ASSESS THE CURRENT STATE OF ONCOLOGY CARE AND RESEARCH AND DETERMINE THE NEED FOR AND IMPACT OF POLICY CHANGES. EXPENSES $8,361,484. INCLUDING GRANTS OF $9,050. REVENUE $0. PATIENT INFORMATION & OTHER: ASCO PROVIDES IMPORTANT INFORMATION TO THE PUBLIC FREE OF CHARGE THROUGH ITS AWARD-WINNING PATIENT EDUCATION WEBSITE, CANCER.NET (WWW.CANCER.NET). CANCER.NET BRINGS THE EXPERTISE AND RESOURCES OF ASCO TO PEOPLE LIVING WITH CANCER AND THOSE WHO CARE FOR AND CARE ABOUT THEM. CANCER.NET PROVIDES ONCOLOGIST-APPROVED INFORMATION TO HELP PATIENTS AND FAMILIES MAKE INFORMED HEALTH CARE DECISIONS. THE SITE OFFERS COMPREHENSIVE GUIDES TO MORE THAN 120 TYPES OF CANCER AND CANCER-RELATED SYNDROMES, INCLUDING DISEASE-SPECIFIC TREATMENT AND SIDE EFFECTS INFORMATION. EXTENSIVE INFORMATION CAN BE FOUND ON NAVIGATING CANCER CARE, COPING WITH CANCER, CLINICAL TRIALS, MANAGING SIDE EFFECTS, CAREGIVING, SURVIVORSHIP, AND RESEARCH AND ADVOCACY; SELECT CONTENT IS AVAILABLE IN SPANISH. CANCER.NET ALSO FEATURES VIDEOS, PODCASTS, AND AN AWARD-WINNING BLOG. CANCER.NET MOBILE, ASCOS AWARD-WINNING FREE MOBILE APPLICATION, PROVIDES A FULLY-FEATURED SET OF TOOLS TO HELP PEOPLE MANAGE THEIR CANCER CARE FROM ANYWHERE. CANCER.NET MOBILE IS SPANISH-ENABLED AND INCLUDES KEY FEATURES SUCH AS APPLE HEALTH INTEGRATION (IOS ONLY), MY HEALTH REPORT TO TRACK DATA ENTERED IN THE APP, SYMPTOM AND MEDICATION TRACKER, TOOLS TO RECORD QUESTIONS AND ANSWERS, TRUSTED INFORMATION FROM CANCER.NET, OPTIONAL PASSCODE LOCK, ICLOUD BACKUP, AND MORE. ASCO ALSO OFFERS ASCO ANSWERS PATIENT EDUCATION MATERIALS AVAILABLE IN PRINT AND/OR PDF. ASCO ANSWERS IS A COLLECTION OF ONCOLOGIST-APPROVED PATIENT EDUCATION MATERIALS DEVELOPED BY ASCO FOR PEOPLE WITH CANCER AND THEIR CAREGIVERS. SELECT TITLES ARE AVAILABLE IN SPANISH. ASCO ANSWERS INCLUDE: o GUIDES TO CANCER: THESE COMPREHENSIVE GUIDES HELP NEWLY DIAGNOSED PATIENTS BETTER UNDERSTAND THEIR DISEASE AND TREATMENT OPTIONS. THEY INCLUDE INFORMATION ABOUT DIAGNOSIS, TREATMENT, SIDE EFFECTS, AND PSYCHOSOCIAL EFFECTS AND ALLOW PATIENTS TO RECORD THE SPECIFICS OF THEIR INDIVIDUAL DIAGNOSIS AND TREATMENT PLAN. o FACT SHEETS: FACT SHEETS PROVIDE AN INTRODUCTION TO A SPECIFIC TYPE OF CANCER, CANCER TREATMENT, OR SIDE EFFECT. EACH INCLUDES AN OVERVIEW OF THE SUBJECT, AN ILLUSTRATION, WORDS TO KNOW, AND QUESTIONS TO ASK THE HEALTH CARE TEAM. o TOPIC-SPECIFIC BOOKLETS: THESE BOOKLETS PROVIDE DETAILED INFORMATION FOR PATIENTS AND CAREGIVERS ABOUT PRACTICAL AND SPECIFIC CONCERNS ON TOPICS SUCH AS ADVANCED CANCER CARE PLANNING, MANAGING THE COST OF CANCER CARE, MANAGING CANCER-RELATED PAIN, MANAGING YOUR WEIGHT AFTER A CANCER DIAGNOSIS, PALLIATIVE CARE, AND STOPPING TOBACCO USE AFTER A CANCER DIAGNOSIS. EXPENSES $8,123,700. INCLUDING GRANTS OF $0. REVENUE $1,165,634.
FORM 990, PART VI, SECTION A, LINE 1	AS OF DECEMBER 31, 2019, THE BOARD OF DIRECTORS OF ASCO INCLUDED 18 MEMBERS WITH THE RIGHT TO VOTE ON ALL MATTERS THAT COME BEFORE THE BOARD OF DIRECTORS. THE BOARD OF DIRECTORS ALSO INCLUDES TWO EX-OFFICIO DIRECTORS WITHOUT THE RIGHT TO VOTE, WHO ARE THE CHIEF EXECUTIVE OFFICER OF ASCO (CEO) AND THE CHAIR OF THE BOARD OF DIRECTORS OF CONQUER CANCER FOUNDATION OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (A NON-PROFIT, 501(C)(3) TAX-EXEMPT RELATED ORGANIZATION OF ASCO). DURING THE REPORTING YEAR, THE BOARD OF DIRECTORS DELEGATED AUTHORITY TO ACT ON ITS BEHALF TO THE EXECUTIVE COMMITTEE OF THE BOARD OF DIRECTORS, CONSISTENT WITH ASCO'S BYLAWS. PURSUANT TO THE BYLAWS, THE VOTING MEMBERS OF THE EXECUTIVE COMMITTEE ARE: THE PRESIDENT, THE PRESIDENT-ELECT, THE CHAIR, THE PAST PRESIDENT, AND THOSE DIRECTORS SERVING THE FINAL YEAR OF THEIR PRESENT TERMS. THE CEO IS A NON-VOTING MEMBER OF THE EXECUTIVE COMMITTEE. ALL EXECUTIVE COMMITTEE MEMBERS ARE MEMBERS OF ASCO'S BOARD OF DIRECTORS. THE SCOPE OF THE EXECUTIVE COMMITTEE'S AUTHORITY IS ESTABLISHED BY ASCO'S BYLAWS, WHICH PROVIDE THAT, EXCEPT TO THE EXTENT SPECIFICALLY PROHIBITED BY RESOLUTION OF THE BOARD OF DIRECTORS OR OTHERWISE PROHIBITED BY LAW, THE EXECUTIVE COMMITTEE OF THE BOARD IS EMPOWERED TO MAKE AND IMPLEMENT MAJOR DECISIONS BETWEEN BOARD MEETINGS AND IT MAY ACT ON ITEMS REQUIRING ACTION PRIOR TO THE NEXT ANNOUNCED BOARD OF DIRECTORS. ALL ACTIONS OF THE EXECUTIVE COMMITTEE ARE REPORTED TO THE BOARD OF DIRECTORS AT THE NEXT MEETING OF THE BOARD OF DIRECTORS IMMEDIATELY FOLLOWING THE ACTION TAKEN BY THE EXECUTIVE COMMITTEE, CONSISTENT WITH ASCO'S BYLAWS. FORM 990, PART VI, SECTION A, LINE 4 IN 2019, THE SOCIETY'S BYLAWS WERE AMENDED TO PROVIDE THAT ASCO MEMBERS WOULD ALSO BE MEMBERS OF THE SAME MEMBERSHIP CLASS OR CLASSES OF THE SOCIETY'S NEWLY ESTABLISHED RELATED 501(C)(6) PROFESSIONAL ORGANIZATION, ASCO ASSOCIATION (D/B/A ASSOCIATION FOR CLINICAL ONCOLOGY). MEMBERS ARE NOW MEMBERS OF BOTH THE SOCIETY AND ITS NEW ASSOCIATION. MEMBERSHIP APPLICATION REVIEW, MEMBER INDUCTION, AND MEMBERSHIP DISCIPLINE AND TERMINATION ARE CONDUCTED SUBJECT TO PROCESSES APPROVED BY BOTH THE SOCIETY'S BOARD OF DIRECTORS AND THE ASSOCIATION'S BOARD OF DIRECTORS.
FORM 990, PART VI, SECTION A, LINE 6	NO ASCO MEMBER IS ENTITLED TO RECEIVE A SHARE OF ASCO'S PROFITS OR EXCESS DUES OR A SHARE OF ASCO'S NET ASSETS UPON DISSOLUTION. THE CATEGORIES OF MEMBERSHIP WITH VOTING RIGHTS AND SPECIFIED RIGHTS ARE AS FOLLOWS: 1. FULL MEMBERS. a. 1.A. FULL MEMBERS ARE (A) EXPERIENCED LICENSED PHYSICIANS OF ANY NATION WHO DEVOTE A MAJORITY OF THEIR PROFESSIONAL ACTIVITY TO CANCER PATIENT CARE AND/OR RESEARCH OR EDUCATION IN THE BIOLOGY, DIAGNOSIS, PREVENTION OR TREATMENT OF HUMAN CANCER (IN EXCEPTIONAL CASES, OTHER PHYSICIANS WHO HAVE MADE SIGNIFICANT CONTRIBUTIONS TO THE FIELD ARE ELIGIBLE FOR FULL MEMBER STATUS), AND (B) OTHER HEALTH PROFESSIONALS AT THE DOCTORAL LEVEL (E.G.,EPIDEMIOLOGISTS, BIOSTATISTICIANS, PUBLIC HEALTH SPECIALISTS, NURSES, OTHER SCIENTISTS, ETC.) OR INDIVIDUALS WITH EQUIVALENT ACADEMIC RANKS WHO DEVOTE A MAJORITY OF THEIR PROFESSIONAL ACTIVITY TO CANCER PATIENT CARE AND/OR RESEARCH OR EDUCATION IN THE BIOLOGY, DIAGNOSIS, PREVENTION OR TREATMENT OF HUMAN CANCER. b.1.B. RIGHTS OF FULL MEMBERS INCLUDE THE RIGHT TO ATTEND MEETINGS, VOTE ON THE ELECTION OF ELECTED DIRECTORS, ELECTED OFFICERS, AND CERTAIN COMMITTEE MEMBERS, AND APPROVE SIGNIFICANT DECISIONS OF THE GOVERNING BODY SUCH AS AMENDMENT TO THE GOVERNING DOCUMENTS AND DISSOLUTION. 2. EMERITUS MEMBERS. a.2.A. EMERITUS MEMBERS ARE FULL, ALLIED PHYSICIAN/DOCTORAL SCIENTIST, INTERNATIONAL CORRESPONDING AND AFFILIATED HEALTH PROFESSIONAL MEMBERS WHO HAVE REQUESTED EMERITUS STATUS AT AGE 70, UPON RETIREMENT OR EARLIER IF PERMANENTLY DISABLED. b.2.B. EMERITUS MEMBERS WHO AT THE TIME OF THE REQUEST WERE FULL MEMBERS RETAIN THE RIGHT TO ATTEND MEETINGS, VOTE ON THE ELECTION OF ELECTED DIRECTORS, ELECTED OFFICERS, AND CERTAIN COMMITTEE MEMBERS, AND APPROVE SIGNIFICANT DECISIONS OF THE GOVERNING BODY SUCH AS AMENDMENT TO THE GOVERNING DOCUMENTS AND DISSOLUTION. 3. HONORARY MEMBERS. a.3.A. HONORARY MEMBERS ARE INDIVIDUALS WHO HAVE MADE AN OUTSTANDING CONTRIBUTION TO CLINICAL ONCOLOGY WHO ARE DESIGNATED AS AN HONORARY MEMBER BY THE BOARD OF DIRECTORS. b.3.B. MEMBERS HAVE THE RIGHT TO ATTEND MEETINGS, VOTE ON THE ELECTION OF ELECTED DIRECTORS, ELECTED OFFICERS, AND CERTAIN COMMITTEE MEMBERS, AND APPROVE SIGNIFICANT DECISIONS OF THE GOVERNING BODY SUCH AS AMENDMENT TO THE GOVERNING DOCUMENTS AND DISSOLUTION.
FORM 990, PART VI, SECTION A, LINE 7A	VOTING MEMBERS OF ASCO ELECT ALL VOTING MEMBERS OF THE ASCO BOARD OF DIRECTORS. THE CATEGORIES OF MEMBERS WHO ARE ELIGIBLE TO VOTE FOR THE ELECTION OF MEMBERS OF THE GOVERNING BODY ARE: FULL MEMBERS, EMERITUS MEMBERS WHO WERE FULL MEMBERS AT THE TIME OF REQUEST FOR EMERITUS MEMBER STATUS, AND HONORARY MEMBERS.
FORM 990, PART VI, SECTION A, LINE 7B	ASCO'S CERTIFICATE OF INCORPORATION MAY ONLY BE AMENDED UPON THE VOTE OF THE MEMBERS ENTITLED TO VOTE, AND THE BYLAWS MAY ONLY BE AMENDED, AND DISSOLUTION OF THE CORPORATION MAY ONLY BE APPROVED WITH THE APPROVAL OF BOTH THE BOARD OF DIRECTORS AND VOTING MEMBERS OF ASCO. THE CATEGORIES OF MEMBERS WHO ARE ELIGIBLE TO VOTE ARE: FULL MEMBERS, EMERITUS MEMBERS WHO WERE FULL MEMBERS AT THE TIME OF REQUEST FOR EMERITUS MEMBER STATUS, AND HONORARY MEMBERS.
FORM 990, PART VI, SECTION B, LINE 11	A DRAFT ELECTRONIC COPY OF THE ASCO FORM 990 WAS SENT, THROUGH A SECURE SITE, TO EACH MEMBER OF THE BOARD OF DIRECTORS AND WAS DISCUSSED AT A MEETING OF THE BOARD. AN ELECTRONIC COPY OF THE FINAL FORM WAS SENT, THROUGH A SECURE SITE, TO EACH MEMBER OF THE BOARD OF DIRECTORS, AND WAS REVIEWED BY THE EXECUTIVE VICE PRESIDENT & CHIEF FINANCIAL OFFICER, THE CHIEF EXECUTIVE OFFICER, AND THE EXECUTIVE VICE PRESIDENT & CHIEF LEGAL OFFICER PRIOR TO FILING.
FORM 990, PART VI, SECTION B, LINE 12C	ASCO MAINTAINS A NUMBER OF WRITTEN CONFLICT OF INTEREST POLICIES AND STANDARDS REGARDING THE DISCLOSURE AND MANAGEMENT OF CONFLICTS OF INTEREST. THESE POLICIES AND STANDARDS COVER ALL ASCO MEMBERS AND EMPLOYEES, DIRECTORS, OFFICERS, COMMITTEE MEMBERS, AND CERTAIN FAMILY MEMBERS (E.G. SPOUSE, DEPENDENT CHILDREN). COVERED INDIVIDUALS ARE ASKED TO DISCLOSE FINANCIAL INTERESTS IN OR OTHER RELATIONSHIPS WITH ENTITIES THAT HAVE RELEVANT COMMERCIAL INTERESTS, INCLUDING EMPLOYMENT OR LEADERSHIP POSITIONS, CONSULTANT OR ADVISORY ROLES, STOCK OWNERSHIP, HONORARIA, RESEARCH FUNDING, AND SERVICE AS AN EXPERT WITNESS. OFFICERS, DIRECTORS AND KEY EMPLOYEES ARE ALSO REQUIRED TO DISCLOSE SERVICE AS AN OFFICER, DIRECTOR, OR TRUSTEE OF ANY OTHER PROFESSIONAL OR ADVOCACY ORGANIZATION RELATING TO SCIENCE OR HEALTH CARE. COMPLETION OF A DISCLOSURE FORM IS REQUIRED AT THE INITIATION OF SERVICE AND UPDATED ANNUALLY THEREAFTER AND WHEN ANY MATERIAL CHANGES OCCUR. ASCO'S CONFLICT OF INTEREST POLICIES ARE INTENDED TO HELP GUIDE THE MANAGEMENT OF ACTUAL, POTENTIAL, AND PERCEIVED CONFLICTS OF INTEREST THROUGH DISCLOSURE OF FINANCIAL INTERESTS OR OTHER RELATIONSHIPS. WHERE THE NATURE AND EXTENT OF A FINANCIAL RELATIONSHIP SUGGEST DISCLOSURE IS NOT ADEQUATE TO MANAGE A REAL OR POTENTIAL CONFLICT, COVERED INDIVIDUALS ARE REQUIRED TO RECUSE THEMSELVES FROM DECISION MAKING. RECUSAL MAY BE SELF-SELECTED, OR MAY BE REQUESTED BY THE COMMITTEE CHAIR, OFFICER, OR EXECUTIVE-LEVEL STAFF MEMBERS. IN ADDITION, IF ASCO WERE TO CONTEMPLATE ENTERING INTO A TRANSACTION OR ARRANGEMENT THAT MIGHT BENEFIT THE PRIVATE INTEREST OF ANY INTERESTED PERSON (I.E. AN ASCO DIRECTOR, PRINCIPAL OFFICER, OR MEMBER OF AN ASCO COMMITTEE WITH BOARD DELEGATED POWERS WHO HAS A DIRECT OR INDIRECT FINANCIAL INTEREST IN THE TRANSACTION), IT MUST FOLLOW A SPECIFIC PROCEDURE TO MANAGE THE CONFLICT, INCLUDING CONSIDERING ALTERATIVE TRANSACTIONS THAT WOULD NOT GIVE RISE TO A CONFLICT OF INTEREST.
FORM 990, PART VI, SECTION B, LINE 15	COMPENSATION OF CHIEF EXECUTIVE OFFICER (CEO): THE DUTIES OF THE CEO OF ASCO INCLUDE SERVING AS: THE CEO OF ASCO, THE CEO OF ASCO'S NON-PROFIT, 501(C)(3) TAX-EXEMPT RELATED ORGANIZATION, CONQUER CANCER FOUNDATION OF ASCO (CC); THE CEO OF ASCO'S NON-PROFIT, 501(C)(6) TAX-EXEMPT RELATED ORGANIZATION, ASCO ASSOCIATION (D/B/A ASSOCIATION FOR CLINICAL ONCOLOGY)(ASSOCIATION), THE PRESIDENT OF QOPI CERTIFICATION PROGRAM, LLC; THE PRESIDENT OF ASCO LEASING LLC, AND THE CHAIR OF THE BOARD OF GOVERNORS OF CANCERLINQ LLC. ALL ORGANIZATIONS LISTED ARE RELATED ORGANIZATIONS OF ASCO. THE WRITTEN EMPLOYMENT CONTRACT BETWEEN THE CEO AND ASCO ADDRESSES COMPENSATION OF THE CEO. THE COMPENSATION OF THE CEO WAS DETERMINED BY THE ASCO BOARD OF DIRECTORS, FOLLOWING THE REVIEW AND RECOMMENDATION OF THE BOARD COMPENSATION COMMITTEE. THE COMPENSATION COMMITTEE CONSULTED WITH INDEPENDENT LEGAL COUNSEL AND ITS INDEPENDENT COMPENSATION CONSULTANT. THE INDEPENDENT COMPENSATION CONSULTANT COLLECTED AND REPORTED ON COMPARABLE MARKET DATA (INCLUDING DATA ON COMPARABLE COMPENSATION FOR SIMILARLY QUALIFIED PERSONS IN FUNCTIONALLY COMPARABLE POSITIONS AT SIMILARLY SITUATED ORGANIZATIONS) AND PROVIDED ITS OPINION THAT THE COMPENSATION FOR THE CEO WAS REASONABLE. THE REVIEW, RECOMMENDATION, AND DETERMINATION OF THE CEO'S COMPENSATION BASED ON THE ABOVE DESCRIBED PROCESS WERE MOST RECENTLY UNDERTAKEN IN 2019. THE COMPENSATION OF THE FOLLOWING POSITIONS WERE CONSIDERED AND APPROVED BY THE ASCO BOARD COMPENSATION COMMITTEE, AFTER RECEIVING THE RECOMMENDATION OF THE CEO AND AND AN INDEPENDENT COMPENSATION CONSULTANT. THE INDEPENDENT COMPENSATION CONSULTANT COLLECTED AND REPORTED ON COMPARABLE MARKET DATA (INCLUDING DATA ON COMPARABLE COMPENSATION FOR SIMILARLY QUALIFIED PERSONS IN FUNCTIONALLY COMPARABLE POSITIONS AT SIMILARLY SITUATED ORGANIZATIONS) AND PROVIDED ITS OPINION THAT THE COMPENSATION FOR THE POSITIONS WAS REASONABLE. - SENIOR VICE PRESIDENT & CHIEF LEGAL OFFICER (SVP & CLO): THE CONSIDERATION AND APPROVAL OF THE COMPENSATION OF THE SVP & CLO BASED ON THE ABOVE DESCRIBED PROCESS WAS MOST RECENTLY UNDERTAKEN IN 2019. - VICE PRESIDENT AND CHIEF FINANCIAL OFFICER (VP & CFO): THE CONSIDERATION AND APPROVAL OF THE COMPENSATION OF THE VP & CFO BASED ON THE ABOVE DESCRIBED PROCESS WERE MOST RECENTLY UNDERTAKEN IN 2019. - SENIOR VICE PRESIDENT & CHIEF MEDICAL OFFICER (SVP & CMO): THE CONSIDERATION AND APPROVAL OF THE COMPENSATION OF THE SVP & CMO BASED ON THE ABOVE DESCRIBED PROCESS WAS MOST RECENTLY UNDERTAKEN IN 2019. - CHIEF DIGITAL OFFICER (CDO): THE CONSIDERATION AND APPROVAL OF THE COMPENSATION OF THE CDO BASED ON THE ABOVE DESCRIBED PROCESS WERE MOST RECENTLY UNDERTAKEN IN 2019. - VICE PRESIDENT, INFORMATION TECHNOLOGY (VP, IT): THE CONSIDERATION AND APPROVAL OF THE COMPENSATION OF THE VP, IT BASED ON THE ABOVE DESCRIBED PROCESS WERE MOST RECENTLY UNDERTAKEN IN 2017. - EXECUTIVE VICE PRESIDENT & CHIEF PHILANTHROPIC OFFICER OF THE CONQUER CANCER FOUNDATION OF CLINICAL ONCOLOGY (CC): THE EXECUTIVE VICE PRESIDENT & CHIEF PHILANTHROPIC OFFICER OF CC IS AN EMPLOYEE OF ASCO. THE CONSIDERATION AND APPROVAL OF THE COMPENSATION OF THE EXECUTIVE VICE PRESIDENT & CHIEF PHILANTHROPIC OFFICER OF CC BASED ON THE ABOVE DESCRIBED PROCESS WERE MOST RECENTLY UNDERTAKEN IN 2019. - CHIEF EXECUTIVE OFFICER OF CANCERLINQ LLC (CEO OF CLQ): THE CONSIDERATION AND APPROVAL OF THE COMPENSATION OF THE CEO OF CLQ BASED ON THE ABOVE DESCRIBED PROCESS WAS MOST RECENTLY UNDERTAKEN IN 2019.
FORM 990, PART VI, SECTION C, LINE 19	ASCO'S GOVERNING DOCUMENTS ARE AVAILABLE TO THE PUBLIC FROM ASCO UPON REQUEST. ASCO'S CERTIFICATE OF INCORPORATION IS ALSO AVAILABLE TO THE PUBLIC THROUGH THE SECRETARY OF STATE OF NEW YORK. ASCO'S CONFLICT OF INTEREST POLICY IS POSTED ON ASCO'S WEBSITE AND IS AVAILABLE TO THE PUBLIC FROM ASCO UPON REQUEST. ASCO'S ANNUAL ACCOMPLISHMENTS AND FINANCIAL INFORMATION IS POSTED ON ASCO'S WEBSITE AND AVAILABLE TO THE PUBLIC UPON REQUEST.
FORM 990, PART XI, LINE 9	LOSS ON INTEREST RATE SWAP ($2,941,592)
FORM 990 PART IX LINE 11G	DESCRIPTION:COMMISSIONS TOTAL FEES:6170594
FORM 990 PART IX LINE 11G	DESCRIPTION:PUBLIC RELATIONS COORDINATOR TOTAL FEES:1115702
FORM 990 PART IX LINE 11G	DESCRIPTION:TEMPORARY STAFF TOTAL FEES:1234733
FORM 990 PART IX LINE 11G	DESCRIPTION:CLINICAL TRIAL SITES TOTAL FEES:2509000
FORM 990 PART IX LINE 11G	DESCRIPTION:OTHER PROFESSIONAL FEES TOTAL FEES:16867390

Schedule R IRS990ScheduleR

Id Disregarded Entities IdDisregardedEntitiesGrp (3 entries)

Address Line1USAddress/AddressLine1Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	EINEIN	Primary ActivitiesPrimaryActivitiesTxt	Legal Domicile StateLegalDomicileStateCd	Total IncomeTotalIncomeAmt	End Of Year AssetsEndOfYearAssetsAmt	Business Name Line1DirectControllingEntityName/BusinessNameLine1Txt
QOPI Certification Program LLC
2318 MILL ROAD SUITE 800	ALEXANDRIA	VA	22314	271629211	accreditation	VA	$986,911	$795,305	ASCO
ASCO LEASING LLC
2318 MILL ROAD SUITE 800	ALEXANDRIA	VA	22314	273378225	RENTAL	VA	$578,110	$697,022	ASCO
CANCERLINQ LLC
2318 MILL ROAD SUITE 800	ALEXANDRIA	VA	22314	472315885	QUALITY IMprv	VA	$65,556,251	$12,454,729	ASCO

Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp (2 entries)

Address Line1USAddress/AddressLine1Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	EINEIN	Primary ActivitiesPrimaryActivitiesTxt	Legal Domicile StateLegalDomicileStateCd	Exempt Code SectionExemptCodeSectionTxt	Public Charity StatusPublicCharityStatusTxt	Business Name Line1DirectControllingEntityName/BusinessNameLine1Txt	Controlled OrganizationControlledOrganizationInd
CONQUER CANCER FOUNDATION OF ASCO
2318 MILL ROAD SUITE 800	ALEXANDRIA	VA	22314	311667995	Grants	VA	501(C)(3)	7	asco	Yes (true)
ASCO ASSOCIATION
2318 MILL ROAD	ALEXANDRIA	VA	22314	833561693	MEMBER SERV.	VA	501(C)(6)		ASCO	Yes (true)

Field	Value	IRS element (for citing)
Receipt Of Int Annts Rnts Rylts	Yes (true)	ReceiptOfIntAnntsRntsRyltsInd
Gift Grnt Or Cap Contri To Oth Org	Yes (true)	GiftGrntOrCapContriToOthOrgInd
Gift Grnt Cap Contri From Oth Org	Yes (true)	GiftGrntCapContriFromOthOrgInd
Loans Or Guarantees To Other Org	false	LoansOrGuaranteesToOtherOrgInd
Loans Or Guarantees From Oth Org	Yes (true)	LoansOrGuaranteesFromOthOrgInd
Div Related Organization	false	DivRelatedOrganizationInd
Asset Sale To Other Org	false	AssetSaleToOtherOrgInd
Asset Purchase From Other Org	false	AssetPurchaseFromOtherOrgInd
Asset Exchange	false	AssetExchangeInd
Rental Of Facilities To Oth Org	Yes (true)	RentalOfFacilitiesToOthOrgInd
Rental Of Fclts From Oth Org	false	RentalOfFcltsFromOthOrgInd
Perform Of Services For Oth Org	Yes (true)	PerformOfServicesForOthOrgInd
Perform Of Services By Other Org	Yes (true)	PerformOfServicesByOtherOrgInd
Sharing Of Facilities	Yes (true)	SharingOfFacilitiesInd
Paid Employees Sharing	Yes (true)	PaidEmployeesSharingInd
Reimbursement Paid To Other Org	false	ReimbursementPaidToOtherOrgInd
Reimbursement Paid By Other Org	false	ReimbursementPaidByOtherOrgInd
Transfer To Other Org	false	TransferToOtherOrgInd
Transfer From Other Org	false	TransferFromOtherOrgInd

Transactions Related Org TransactionsRelatedOrgGrp (7 entries)

Transaction TypeTransactionTypeTxt	InvolvedInvolvedAmt	Method Of Amount DeterminationMethodOfAmountDeterminationTxt
conquer cancer foundation of asco
A, J	$602,493	FMV
conquer cancer foundation of asco
b	$1,764,000	fmv
conquer cancer foundation of asco
c	$7,525,300	fmv
conquer cancer foundation of asco
e	$54,777,714	fmv
conquer cancer foundation of asco
m	$3,150,000	fmv
conquer cancer foundation of asco
n	$1,082,077	fmv
conquer cancer foundation of asco
o	$5,955,791	fmv